<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_h8qC6yB">Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life A Randomized Clinical Trial</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability  status="unknown">
					<licence/>
					<p type="raw">© 2018 American Medical Association. All rights reserved. © 2018 American Medical Association. All rights reserved. © 2018 American Medical Association. All rights reserved. © 2018 American Medical Association. All rights reserved. © 2018 American Medical Association. rights reserved. © 2018 American Medical Association. rights reserved. © 2018 American Medical Association. All rights reserved. © 2018 American Medical Association. All rights reserved.</p>
				</availability>
				<date type="published" when="2018-09-25">September 25, 2018.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>PhD;</roleName><forename type="first">Colin</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
							<email>colin.espie@ndcn.ox.ac.uk</email>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Richard</forename><surname>Emsley</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Simon</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Christopher</forename><surname>Gordon</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Christopher</forename><forename type="middle">L</forename><surname>Drake</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD;</roleName><forename type="first">;</forename><forename type="middle">A Niroshan</forename><surname>Siriwardena</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">John</forename><surname>Cape</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Jason</forename><forename type="middle">C</forename><surname>Ong</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Bryony</forename><surname>Sheaves</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Russell</forename><surname>Foster</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Daniel</forename><surname>Freeman</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Joan</forename><surname>Costa-Font</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Antonia</forename><surname>Marsden</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Annemarie</forename><forename type="middle">I</forename><surname>Luik</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<note type="raw_affiliation">Sleep &amp; Circadian Neuroscience Institute , Nuffield Department of Clinical Neurosciences , University of Oxford , Sir William Dunn School of Pathology , South Parks Road , Oxford OX1 3RE , United Kingdom</note>
								<orgName type="department" key="dep1">Sleep &amp; Circadian Neuroscience Institute</orgName>
								<orgName type="department" key="dep2">Nuffield Department of Clinical Neurosciences</orgName>
								<orgName type="department" key="dep3">Sir William Dunn School of Pathology</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<addrLine>South Parks Road</addrLine>
									<postCode>OX1 3RE</postCode>
									<settlement>Oxford</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<note type="raw_affiliation">Sleep &amp; Circadian Neuroscience Institute , Nuffield Department of Clinical Neurosciences , University of Oxford , Oxford , United Kingdom (</note>
								<orgName type="department" key="dep1">Sleep &amp; Circadian Neuroscience Institute</orgName>
								<orgName type="department" key="dep2">Nuffield Department of Clinical Neurosciences</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<note type="raw_affiliation">Espie , Kyle , Foster , Luik );</note>
								<orgName type="department">Foster</orgName>
								<orgName type="institution" key="instit1">Espie</orgName>
								<orgName type="institution" key="instit2">Kyle</orgName>
								<address>
									<region>Luik</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<note type="raw_affiliation">Big Health Ltd , London , United Kingdom</note>
								<orgName type="institution">Big Health Ltd</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<note type="raw_affiliation">(Espie , Cape , Luik) ; Biostatistics &amp; Health Informatics Department ,</note>
								<orgName type="department">Biostatistics &amp; Health Informatics Department</orgName>
								<orgName type="institution">(Espie</orgName>
								<address>
									<settlement>Cape</settlement>
									<region>Luik</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff5">
								<note type="raw_affiliation">Institute of Psychiatry , Psychology &amp; Neuroscience , King&apos;s College London , London , United Kingdom (</note>
								<orgName type="department" key="dep1">Institute of Psychiatry</orgName>
								<orgName type="department" key="dep2">Psychology &amp; Neuroscience</orgName>
								<orgName type="institution">King&apos;s College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<note type="raw_affiliation">Emsley) ; Susan Wakil School of Nursing and Midwifery , The University of Sydney , Sydney , Australia ( Gordon );</note>
								<orgName type="department" key="dep1">Emsley)</orgName>
								<orgName type="department" key="dep2">Susan Wakil School of Nursing and Midwifery</orgName>
								<orgName type="laboratory">Gordon</orgName>
								<orgName type="institution">The University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff7">
								<note type="raw_affiliation">CIRUS Centre for Integrated Research and Understanding of Sleep , Woolcock Institute of Medical Research , University of Sydney , Sydney , Australia (</note>
								<orgName type="department">Woolcock Institute of Medical Research</orgName>
								<orgName type="laboratory">CIRUS Centre for Integrated Research and Understanding of Sleep</orgName>
								<orgName type="institution">University of Sydney</orgName>
								<address>
									<settlement>Sydney</settlement>
									<country key="AU">Australia</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<note type="raw_affiliation">Gordon) ; Department of Sleep Disorders and Research Center , Henry Ford Health System , Detroit , Michigan (</note>
								<orgName type="department" key="dep1">Gordon)</orgName>
								<orgName type="department" key="dep2">Department of Sleep Disorders and Research Center</orgName>
								<orgName type="institution">Henry Ford Health System</orgName>
								<address>
									<settlement>Detroit</settlement>
									<region>Michigan</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff9">
								<note type="raw_affiliation">Drake) ; School of Health and Social Care , University of Lincoln , Lincoln , United Kingdom (</note>
								<orgName type="department" key="dep1">Drake)</orgName>
								<orgName type="department" key="dep2">School of Health and Social Care</orgName>
								<orgName type="institution">University of Lincoln</orgName>
								<address>
									<settlement>Lincoln</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff10">
								<note type="raw_affiliation">Siriwardena) ; Division of Psychology and Language Sciences , Faculty of Brain Sciences , University College London , London , United Kingdom (</note>
								<orgName type="department" key="dep1">Siriwardena)</orgName>
								<orgName type="department" key="dep2">Division of Psychology and Language Sciences</orgName>
								<orgName type="department" key="dep3">Faculty of Brain Sciences</orgName>
								<orgName type="institution">University College London</orgName>
								<address>
									<settlement>London</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff11">
								<note type="raw_affiliation">Cape) ; Feinberg School of Medicine , Northwestern University , Chicago , Illinois ( Ong) ;</note>
								<orgName type="department" key="dep1">Cape)</orgName>
								<orgName type="department" key="dep2">Feinberg School of Medicine</orgName>
								<orgName type="laboratory">Ong)</orgName>
								<orgName type="institution">Northwestern University</orgName>
								<address>
									<settlement>Chicago</settlement>
									<region>Illinois</region>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff12">
								<note type="raw_affiliation">Sleep &amp; Circadian Neuroscience Institute , Department of Psychiatry , University of Oxford , Oxford , United Kingdom (</note>
								<orgName type="department" key="dep1">Sleep &amp; Circadian Neuroscience Institute</orgName>
								<orgName type="department" key="dep2">Department of Psychiatry</orgName>
								<orgName type="institution">University of Oxford</orgName>
								<address>
									<settlement>Oxford</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff13">
								<note type="raw_affiliation">Sheaves , Freeman) ; Department of Health Policy , The London School of Economics and Political Science , London , United Kingdom (Costa</note>
								<orgName type="department" key="dep1">Freeman)</orgName>
								<orgName type="department" key="dep2">Department of Health Policy</orgName>
								<orgName type="institution" key="instit1">Sheaves</orgName>
								<orgName type="institution" key="instit2">The London School of Economics and Political Science</orgName>
								<address>
									<settlement>London</settlement>
									<country>United Kingdom (Costa</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff14">
								<note type="raw_affiliation">-Font) ; Centre for Biostatistics , School of Health Sciences , The University of Manchester , Manchester , United Kingdom</note>
								<orgName type="department" key="dep1">-Font)</orgName>
								<orgName type="department" key="dep2">Centre for Biostatistics</orgName>
								<orgName type="department" key="dep3">School of Health Sciences</orgName>
								<orgName type="institution">The University of Manchester</orgName>
								<address>
									<settlement>Manchester</settlement>
									<country key="GB">United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main" xml:id="_gD2ZyXB">Effect of Digital Cognitive Behavioral Therapy for Insomnia on Health, Psychological Well-being, and Sleep-Related Quality of Life A Randomized Clinical Trial</title>
					</analytic>
					<monogr>
						<imprint>
							<date type="published" when="2018-09-25">September 25, 2018.</date>
						</imprint>
					</monogr>
					<idno type="MD5">65727C6E67F88D7686267ED06EC7DCB0</idno>
					<idno type="DOI">10.1001/jamapsychiatry.2018.2745</idno>
					<note type="submission">Accepted for Publication: August 4, 2018.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T13:12+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_8rwCaX4"><p xml:id="_ZY8GWU7"><s xml:id="_h54SVHc">IMPORTANCE Digital cognitive behavioral therapy (dCBT) is a scalable and effective intervention for treating insomnia.</s><s xml:id="_PC9rq4m">Most people with insomnia, however, seek help because of the daytime consequences of poor sleep, which adversely affects quality of life.</s></p><p xml:id="_8jQCQ6E"><s xml:id="_HeK2bHX">OBJECTIVES To investigate the effect of dCBT for insomnia on functional health, psychological well-being, and sleep-related quality of life and to determine whether a reduction in insomnia symptoms was a mediating factor.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pgvQmkM">DESIGN, SETTING, AND PARTICIPANTS</head><p xml:id="_XK5PA9S"><s xml:id="_jarazV2">This online, 2-arm, parallel-group randomized trial comparing dCBT for insomnia with sleep hygiene education (SHE) evaluated 1711 participants with self-reported symptoms of insomnia.</s><s xml:id="_cTJnwDp">Participants were recruited between December 1, 2015, and December 1, 2016, and dCBT was delivered using web and/or mobile channels plus treatment as usual; SHE comprised a website and a downloadable booklet plus treatment as usual.</s><s xml:id="_RmHMvjC">Online assessments took place at 0 (baseline), 4 (midtreatment), 8 (posttreatment), and 24 (follow-up) weeks.</s><s xml:id="_hUR2EYT">Programs were completed within 12 weeks after inclusion.</s></p><p xml:id="_S8qWDXx"><s xml:id="_693cE7j">MAIN OUTCOMES AND MEASURES Primary outcomes were scores on self-reported measures of functional health (Patient-Reported Outcomes Measurement Information System: Global Health Scale; range, 10-50; higher scores indicate better health); psychological well-being (Warwick-Edinburgh Mental Well-being Scale; range, 14-70; higher scores indicate greater well-being); and sleep-related quality of life (Glasgow Sleep Impact Index; range, 1-100; higher scores indicate greater impairment).</s><s xml:id="_r2jNd25">Secondary outcomes comprised mood, fatigue, sleepiness, cognitive failures, work productivity, and relationship satisfaction.</s><s xml:id="_4rkEd7T">Insomnia was assessed with the Sleep Condition Indicator (range: 0-32; higher scores indicate better sleep).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_yYDeFEy">RESULTS</head><p xml:id="_fYSyf8J"><s xml:id="_Twruqrw">Of the 1711 participants included in the intention-to-treat analysis, 1329 (77.7%) were female, mean (SD) age was 48.0 (13.8) years, and 1558 (91.1%) were white.</s><s xml:id="_pN5EZZe">Use of dCBT was associated with a small improvement in functional health compared with SHE (adjusted difference [95% CI] at week 4, 0.90 [0.40-1.40];</s><s xml:id="_zT9wv47">week 8, 1.76 [1.24-2.28];</s><s xml:id="_A2B2z93">week 24, 1.76 [1.22-2.30])</s><s xml:id="_WbAuVk6">and psychological well-being (adjusted difference [95% CI] at week 4, 1.04 [0.28-1.80];</s><s xml:id="_FjPXtUY">week 8, 2. 68 [1.89-3.47];</s><s xml:id="_VdexmCc">week 24, 2.95 [2.13-3.76]),</s><s xml:id="_cGx5MGx">and with a large improvement in sleep-related quality of life (at week 4, -8.76 [-11.83 to -5.69]; week 8,  -17.60 [-20.81 to -14.39]; week 24, -18.72 [-22.04 to -15.41]) (all P &lt; .01).</s><s xml:id="_n32smNe">A large improvement in insomnia mediated these outcomes (range mediated, 45.5%-84.0%).</s></p><p xml:id="_CNcrfAy"><s xml:id="_zsNc829">CONCLUSIONS AND RELEVANCE Use of dCBT is effective in improving functional health, psychological well-being, and sleep-related quality of life in people reporting insomnia symptoms.</s><s xml:id="_VPd7jkD">A reduction in insomnia symptoms mediates these improvements.</s><s xml:id="_E4aFJ6t">These results confirm that dCBT improves both daytime and nighttime aspects of insomnia, strengthening existing recommendations of CBT as the treatment of choice for insomnia.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="4" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="5" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="6" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="7" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="8" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="9" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
		<surface n="10" ulx="0.0" uly="0.0" lrx="612.0" lry="792.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_VrtMbuJ">I</head><p xml:id="_gByAZsB"><s xml:id="_vgmtEkr">nsomnia disorder, comprising reports of poor sleep with associated daytime effects occurring 3 or more nights per week for 3 or more months, <ref type="bibr" target="#b0">1</ref> presents in 10% to 12% of adults. <ref type="bibr" target="#b1">[2]</ref><ref type="bibr" target="#b2">[3]</ref></s><s xml:id="_K7xQFNS">3]<ref type="bibr" target="#b3">[4]</ref> In addition, insomnia is associated with mental health disorders, <ref type="bibr" target="#b4">5</ref> cardiovascular disease, <ref type="bibr" target="#b5">6</ref> and type 2 diabetes. <ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b7">8</ref></s><s xml:id="_ZYp5Jhz">Increased fatigue, impaired work productivity, reduced quality of life, and relationship dissatisfaction are also common in those with insomnia. <ref type="bibr" target="#b8">[9]</ref><ref type="bibr" target="#b9">[10]</ref></s><s xml:id="_8scSVWt">0]<ref type="bibr" target="#b10">[11]</ref> Such impaired functioning is an important driver for help-seeking behavior. <ref type="bibr" target="#b11">12</ref></s><s xml:id="_ntGNSUD">he recommended intervention for insomnia is cognitive behavioral therapy (CBT), <ref type="bibr" target="#b12">[13]</ref><ref type="bibr" target="#b13">[14]</ref><ref type="bibr" target="#b14">[15]</ref><ref type="bibr" target="#b15">[16]</ref> a psychological treatment designed to break patterns of maladaptive thinking and behavior.</s><s xml:id="_mhBBYHN">Cognitive behavioral therapy comprises a behavioral component (stimulus control, sleep restriction, and relaxation) combined with a cognitive (managing sleep-related worries, racing mind, and intrusive thoughts) and an educational (sleep hygiene) component.</s><s xml:id="_PnQX3NX">Meta-analyses indicate that CBT has moderate to large and durable effects on sleep quality, sleep efficiency, sleep-onset latency, and wake time after sleep onset. <ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref></s><s xml:id="_M6wqru6">8]<ref type="bibr" target="#b18">[19]</ref> Moreover, recent meta-analyses indicate that digital CBT (dCBT), delivered using automated web platforms or a mobile app, <ref type="bibr" target="#b19">20</ref> is also efficacious. <ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref></s><s xml:id="_TymEJAW">The effects of CBT and dCBT on the nighttime symptoms of insomnia, therefore, appear robust.</s><s xml:id="_jZgVWH3">However, daytime symptoms are a core part of insomnia disorder, integral to its clinical presentation.</s><s xml:id="_55XbtHS">Improving constructs such as functional health, psychological wellbeing, and quality of life may therefore be crucial to treating insomnia satisfactorily.</s></p><p xml:id="_bWcWuRS"><s xml:id="_CBYPMZc">We investigated the attributable effect of a reduction in insomnia symptoms after receiving dCBT for insomnia on 3 key areas of quality of life: functional health status, psychological well-being, and patient-generated, sleep-related quality of life.</s><s xml:id="_wbG6tZg">Although there is evidence that CBT may yield generalized benefits in both the general population and patient groups <ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref><ref type="bibr" target="#b24">[25]</ref><ref type="bibr" target="#b25">[26]</ref><ref type="bibr" target="#b26">[27]</ref><ref type="bibr" target="#b27">[28]</ref><ref type="bibr" target="#b28">[29]</ref> and some primary data that CBT for insomnia may reduce depressive or anxiety symptoms, <ref type="bibr" target="#b29">[30]</ref><ref type="bibr" target="#b30">[31]</ref><ref type="bibr" target="#b31">[32]</ref><ref type="bibr" target="#b32">[33]</ref><ref type="bibr" target="#b33">[34]</ref> evidence is mixed, <ref type="bibr" target="#b34">35,</ref><ref type="bibr" target="#b35">36</ref> and an adequately powered, definitive trial investigating functional health status, psychological well-being, and a patient-generated assessment of quality of life has not yet been conducted.</s><s xml:id="_2m9sMYg">Moreover, we wanted to conduct a formal test of the mediating effect of improved insomnia symptoms on these outcomes.</s></p><p xml:id="_CZVHfF4"><s xml:id="_Pg88vvq">Our primary hypotheses were that dCBT for insomnia would improve functional health status and psychological wellbeing and would reduce sleep-related quality-of-life impairment at weeks 4, 8, and 24 (research question [RQ] 1) and that the effect of dCBT on these outcomes at weeks 8 and 24 would be mediated by a reduction in insomnia symptoms measured at weeks 4 and 8, respectively (RQ 2).</s><s xml:id="_f4Fy6w2">Our secondary hypotheses were that dCBT would also improve domains of personal functioning (negative mood, fatigue, and relationship dysfunction) and daytime performance (sleepiness, concentration, and productivity) at weeks 4 and 8 (RQ 3), improvements would be maintained at the week 24 follow-up, and the effect of dCBT at weeks 8 and 24 would be mediated by a reduction in insomnia complaints at weeks 4 and 8, respectively (RQ 4).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gjeTuVc">Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MHuvbA4">Research Design</head><p xml:id="_tHruQGg"><s xml:id="_N47VPyS">The study was an online, 2-arm, single-blind, parallel-group, superiority randomized clinical trial of dCBT (Digital Insomnia Therapy to Assist Your Life as Well as Your Sleep [DIALS]) in addition to any treatment the participant was previously receiving (treatment as usual [TAU]) vs sleep hygiene education (SHE) in addition to TAU.</s><s xml:id="_qKcWUJP">We used simple randomization with an allocation ratio of 1:1 as recommended for large clinical trials. <ref type="bibr" target="#b36">37</ref></s><s xml:id="_pTh6DHR">Randomization was carried out by an outside automated online system (surveygizmo.eu),</s><s xml:id="_RCX3kGc">ensuring that allocation could not be influenced by the research team.</s><s xml:id="_CpenhnK">The trial design and progress of participants through the trial are summarized in the Figure .</s><s xml:id="_GZT6TPp">Screening, informed consent, assessments, allocation to condition, and delivery of the interventions were carried out entirely online.</s><s xml:id="_jYNvUYG">Participants were recruited between December 1, 2015, and December 1, 2016; programs were completed within 12 weeks after inclusion.</s><s xml:id="_pgvHNnd">The study received ethical approval from the University of Oxford Medical Sciences Inter-Divisional Ethics Committee (ref MS-IDREC-C2-2015-024), and participants provided online informed consent.</s><s xml:id="_DkhPNSM">The DIALS trial has been registered at <ref type="url" target="http://www.isrctn.com">http:  //www.isrctn.com</ref></s><s xml:id="_YmdyGPT">(ISRCTN 60530898); the protocol has been published and is available in Supplement 1. <ref type="bibr" target="#b37">38</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_DJENQut">Participants</head><p xml:id="_acW7J4y"><s xml:id="_yGmXSpZ">According to the original protocol, a sample size of 433 participants per treatment group was required to detect a standardized effect size of 0.25 with 90% power, assuming a significance level of P &lt; .01667</s><s xml:id="_C3BCQnP">(corrected for 3 primary outcomes), and to detect a large mediation effect with more than 80% power.</s><s xml:id="_N45NRmH">To account for 13% attrition, we increased the sample size to 500 per treatment arm.</s><s xml:id="_YmxeMCM">During the trial, we further extended recruitment because the attrition rate was larger than expected.</s><s xml:id="_d6sJ2R9">A total of 1718 participants enrolled, and the final sample comprised 1711 participants because 7 participants entered the trial twice.</s><s xml:id="_6KAKkUX">For each of these 7 participants, a single entry contributed to the analyses.</s><s xml:id="_K62wrMp">When both entries were randomized to the same condition, the response with the most completed data was selected; when entries were randomized to different groups, the first response was selected unless the participant accessed treatment; if treatment was accessed, the response corresponding with the treatment allocation was used.</s><s xml:id="_4YDC78P">Inclusion and exclusion criteria have been reported earlier and are available in Supplement 1. <ref type="bibr" target="#b37">38</ref> Briefly, inclusion criteria comprised the following: a positive screening results based on the DSM-5 criteria for insomnia disorder; a score of 16 or less on the 8-item Sleep Condition Indicator (SCI; scale, 0-4; range: 0-32, with higher scores indicating better sleep); 39 aged 18 years or older; reliable internet access; and ability to read and understand English.</s><s xml:id="_rr6yp6b">We screened for comorbid conditions and medication use at baseline but excluded only those people whose health was expected to necessitate hospital admission or who had a life expectancy of less than 6 months, who currently received psychological treatment for insomnia or were expecting treatment within 6 months, and who reported suicidal thoughts.</s><s xml:id="_yYqkgY9">We did not exclude participants taking medication for sleep problems or for any other physical or mental health problem.</s><s xml:id="_KEqhK9J">Several methods were used to direct people to the online recruitment page.</s><s xml:id="_KqYZzs4">Persons who had completed previous sleep surveys (ie, Great British Sleep Survey 40 ; World Sleep Survey 41 ) were contacted by email, a recruitment button was placed on an insomnia intervention website, <ref type="bibr" target="#b41">42</ref> advertisements were placed on Facebook and announce-ments on Twitter, and information about the study was presented via broadcast media.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_stqwbmh">Intervention</head><p xml:id="_cnDqzDZ"><s xml:id="_87YanDU">Digital cognitive behavioral therapy was delivered using the Sleepio program (Big Health Ltd) <ref type="bibr" target="#b42">43</ref> and an associated iOS app (Big Health Ltd).</s><s xml:id="_yZC4DyD">The program is fully automated, and its underlying algorithms feed the delivery of information, support, and advice in a personally tailored manner.</s><s xml:id="_kj8MkXK">Delivery is structured into 6 sessions typically lasting 20 minutes each, and participants had access to the intervention for up to 12 weeks.</s><s xml:id="_wUqgZkP">Treatment content is based on CBT manuals <ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref> and includes behavioral, cognitive, and educational components.</s><s xml:id="_RMk977E">A more extensive description can be found in the study protocol (Supplement 1). <ref type="bibr" target="#b37">38</ref></s><s xml:id="_EkfzwdC">The program has been evaluated in multiple randomized clinical trials. <ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b42">43,</ref><ref type="bibr" target="#b46">[47]</ref><ref type="bibr" target="#b47">[48]</ref></s><s xml:id="_wutEuZd">]<ref type="bibr" target="#b48">[49]</ref><ref type="bibr" target="#b49">[50]</ref> SHE was selected for the control arm because this is the behavioral comparator that people with insomnia are most typically offered in routine care.</s><s xml:id="_k2WaRQR">SHE therefore was based on recognized sleep hygiene advice, for example, recommendations about bed routines and use of alcohol and caffeine. <ref type="bibr" target="#b45">46,</ref><ref type="bibr">51</ref></s><s xml:id="_M2S6X76">o ensure consistency of approach and content, SHE was delivered on a dedicated study webpage where materials could be viewed and downloaded in a single session. .</s><s xml:id="_t5QHDk5">Trial Design for the Digital Insomnia Therapy to Assist Your Life as Well as Your Sleep (DIALS) Study 9997 Individuals screened for eligibility 2275 Started baseline assessment (online) 7722 Excluded 7352 Did not meet inclusion criteria 193 Did not continue after inclusion 177 Did not consent 564 Excluded 303 Reported suicidal thoughts 254 Quit during baseline survey 7 Completed double baseline surveys 853 Randomized to receive dCBT 413 Completed all 6 sessions 198 Completed 1 to 3 sessions 164 Did not start program (reasons unknown) 78 Completed 4 to 5 sessions 858 Randomized to receive SHE 759 Received SHE as randomized 99 Did not receive SHE (reasons unknown) 550 Contributed data at 4 wk 551 Contributed data at 4 wk 468 Contributed data at 8 wk 517 Contributed data at 8 wk 411 Contributed data at 24 wk 495 Contributed data at 24 wk 853 Included in intention-to-treat analysis 858 Included in intention-to-treat analysis 1711 Randomized dCBT indicates digital cognitive behavioral therapy; SHE, sleep hygiene education.</s><s xml:id="_fwJKzqj">Effect of Digital Cognitive Behavioral Therapy for Insomnia on Measures of Health and Well-being Original Investigation Research jamapsychiatry.com</s><s xml:id="_gUVDNUF">(Reprinted) JAMA Psychiatry January 2019 Volume 76, Number 1</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_MzzKDVX">Measurements Assessment Points</head><p xml:id="_EpG54ae"><s xml:id="_4Ufp6X2">Assessments took place at weeks 0 (baseline), 4 (midtreatment), 8 (posttreatment), and 24 (follow-up).</s><s xml:id="_rWTWw6J">At week 25, all participants in the control group (SHE) were offered dCBT, which finished the controlled element of the trial.</s><s xml:id="_j8YX3UK">Uncontrolled follow-up data were collected at week 36 and week 48; these data are not presented herein.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_wypNba5">Primary Outcomes</head><p xml:id="_Z85n2TB"><s xml:id="_VBqqpHX">The 3 primary measures used to index physical health, psychological well-being, and sleep-related quality of life were the Patient-Reported Outcomes Measurement Information System: Global Health scale <ref type="bibr" target="#b51">52</ref> for physical health (PROMIS-10; 10 items scored 1 to 5; range: 10-50, with higher scores indicating better health), the Warwick-Edinburgh Mental Wellbeing Scale <ref type="bibr" target="#b52">53</ref> for psychological well-being (WEMWBS, 14 items scored 1 to 5; range: 14-70, with higher scores indicating better well-being), and the Glasgow Sleep Impact Index 54 (GSII), a patient-generated outcome rating in which participants rate self-defined sleep-related impairments (range: 0-100, with higher scores indicating greater impairment).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_2TzR92v">Secondary Outcomes</head><p xml:id="_PeRkcsb"><s xml:id="_MKE26jW">Secondary outcomes related to specific measurement of 6 areas of daytime consequences typically associated with the clinical diagnosis of insomnia disorder. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b9">10</ref></s><s xml:id="_Nr768vQ">These outcomes were mood SHP] and 1 item on job satisfaction <ref type="bibr" target="#b60">61</ref> ), and sleepiness (8-item Epworth Sleepiness Scale <ref type="bibr" target="#b61">62</ref> [ESS]; scale, 0-3; range: 0-24]).</s><s xml:id="_JBfxHWN">As an exploratory measure, participants also completed 1 item about their general life satisfaction. <ref type="bibr" target="#b62">63</ref></s><s xml:id="_jqYV9Vm">To appraise the mediating effects of improvement of insomnia symptoms per se, we used the SCI. <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b54">55</ref></s><s xml:id="_yKsjsps">At week 8, potential adverse effects were assessed by asking participants to rate a number of potential adverse effects for frequency and severity. <ref type="bibr" target="#b63">64</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_mKhN8Zw">Statistical Analysis</head><p xml:id="_KE3teGa"><s xml:id="_BASjtse">All analysis were performed as intention to treat and blinded using Stata version 14 (StataCorp).</s><s xml:id="_BdRrmgR">In accordance with the Consolidated Standards of Reporting Trials guidelines, all participant flow is reported, including descriptive statistics of recruitment, dropout, and completeness of interventions.</s></p><p xml:id="_EGsQ45r"><s xml:id="_QW8p4yE">The main efficacy analysis was based on randomized allocation including all participants with an outcome recorded at the relevant time point.</s><s xml:id="_a8Yb6ju">No interim analyses for efficacy or futility were conducted.</s></p><p xml:id="_FaS6YSZ"><s xml:id="_FYS9mwu">Each primary outcome was analyzed using a linear mixedeffects model to account for the repeated measures at 4, 8, and 24 weeks. <ref type="bibr" target="#b64">65</ref></s><s xml:id="_AnTMzfK">This method implicitly accounts for missing-at-random outcome data.</s><s xml:id="_daVhfN3">The baseline outcome measure, treatment assignment, and categorical time point were included as fixed effects, with a random participant-level effect.</s><s xml:id="_ppmhxSh">Adjusted, absolute between-group changes in outcome at each time point were obtained by including an interaction term between time point and treatment assignment in each model.</s><s xml:id="_VGRcd2b">Results are presented with 95% CIs and 2-sided P values.</s><s xml:id="_qhzXzrd">Cohen d standardized effect sizes were estimated by dividing the adjusted between-group difference by the baseline pooled SD of the corresponding outcome.</s><s xml:id="_p5sz5dp">Assumptions of normality were assessed graphically using histograms.</s><s xml:id="_tBjszv9">The robustness of the assumptions regarding missing outcome data were examined in a series of sensitivity analyses (pattern mixture models, inclusion of baseline characteristics associated with having a missing outcome, and last observation carried forward).</s><s xml:id="_rY7QbKV">Secondary outcomes were analyzed using similar mixedeffects models as the primary outcomes.</s></p><p xml:id="_fRPyRED"><s xml:id="_S2Wdmfq">A series of linear mixed-effects models were fitted to assess the extent to which the effect of the intervention on each outcome at 8 weeks was mediated by changes in insomnia at 4 weeks.</s><s xml:id="_4zgwZd6">The total effect of the intervention on outcome at 8 weeks was estimated from a model adjusting for baseline SCI but not the baseline outcome.</s><s xml:id="_YeyNTnc">The direct effect of the intervention at 8 weeks was estimated from a model adjusting for baseline SCI and SCI at 4 weeks.</s><s xml:id="_F3vYEaw">The effect of SCI at 4 weeks was also extracted from this model and multiplied by the estimated effect of the intervention on SCI at 4 weeks to obtain the indirect effect.</s><s xml:id="_guSdF6p">This approach is similar to that described by Baron and Kenny 66 but uses linear mixed-effects models. <ref type="bibr" target="#b66">67</ref></s><s xml:id="_HPGuUkj">he percentage mediated, estimated as the indirect effect divided by the total effect, was obtained.</s><s xml:id="_sb6ubcf">The extent of mediation of the outcome effects at 24 weeks by insomnia at 8 weeks was evaluated in the same way.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_GH63hAK">Results</head><p xml:id="_9aY9gyE"><s xml:id="_VzA3sXB">The final sample comprised 1711 adults, of whom 1329 (77.7%) were female and the mean (SD) age was 48.0 (13.8) years; 1558 (91.1%) were white, 45 (0.3%) were Asian, 19 (0.1%) were black, 36 (0.2%) were of mixed race/ethnicity, 35 (0.2%) were of another race/ethnicity, and 17 (0.1%) did not wish to state race/ ethnicity.</s><s xml:id="_JB6MTvH">Participants were recruited between December 1, 2015, and December 1, 2016, and allocated to either dCBT plus TAU (n = 853) or SHE plus TAU (n = 858).</s><s xml:id="_mdkg6kg">An overview of sample descriptive statistics and baseline scores for the primary and secondary outcomes can be found in Table <ref type="table" target="#tab_1">1</ref>.</s><s xml:id="_vDPsbdr">Full details of sample characteristics and missing data can be found in eTable 1 in Supplement 2. Dropout from study assessments was greater in the treatment group than in the control group (Figure).</s></p><p xml:id="_CSYf7d2"><s xml:id="_7P7jjY5">In the dCBT group, 689 of the 853 participants (80.8%) logged on for at least 1 session, 491 participants (57.6%) completed at least 4 sessions, and 413 participants (48.4%) completed all 6 sessions (Figure ).</s><s xml:id="_GGSyDS3">Sleep hygiene education was accessed at least once by 759 of 858 participants (88.5%).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_gxhJgfW">Treatment Effects on Primary Outcomes</head><p xml:id="_9HUKcdV"><s xml:id="_aHGnwMq">At weeks 4, 8, and 24, dCBT was associated with significant improvement in global health (Cohen d for week 4, 0.16; week</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_UGKsGSf">Mediation Analysis</head><p xml:id="_SUzbyNE"><s xml:id="_TccdnRr">The results of the mediation analyses can be found in Table <ref type="table" target="#tab_4">3</ref> (indirect effects, RQ 2).</s><s xml:id="_7XpYJKF">The mediator (SCI) demonstrated an improvement compared with SHE (Cohen d for week 4, 0.89; week 8, 1.51; and week 24, 1.51; all P &lt; .01</s><s xml:id="_De8gzB7">Table <ref type="table" target="#tab_5">4</ref>).</s><s xml:id="_VKtA9Pk">When we considered functional health on PROMIS-10 as the outcome, the proportion of the effect of dCBT on PROMIS-10 score at 8 weeks that was mediated by changes in insomnia symptoms at 4 weeks was 50.5%, and the proportion of the effect of the intervention on PROMIS-10 scores at 24 weeks that was mediated by changes in insomnia symptoms at 8 weeks was 83.8%.</s><s xml:id="_ju2vSaV">For psychological well-being, these values were 47.0% at 8 weeks and 74.9% at 24 weeks.</s><s xml:id="_m6meftW">When we considered sleeprelated quality of life, with GSII (rank 1: the most important im-pairment) as the outcome, the proportion of the effect of the intervention on GSII at 8 weeks that was mediated by changes in insomnia symptoms was 45.5% and increased to 65.9% at 24 weeks.</s><s xml:id="_u8zKW3u">eTable 2 in Supplement 2 provides mediation analyses on PROMIS subscales and the GSII total score and secondand third-ranked reported impairments.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_3Q2gwHy">Treatment Effects on Secondary Outcomes</head><p xml:id="_PDT52mC"><s xml:id="_sfdUwvy">Symptoms of depression (PHQ-9), anxiety (GAD-7), sleepiness (ESS), and cognitive failures (CFQ) all demonstrated significant differences in favor of dCBT at weeks 4, 8, and 24, reflecting small effect sizes (Table <ref type="table" target="#tab_5">4</ref>, RQ 3).</s><s xml:id="_rE9g84M">There were moderate to large effects observed at weeks 4, 8, and 24 for fatigue (FFS).</s><s xml:id="_Cu4TGex">On the WPAI, productivity at work (presenteeism) that was attributed to sleep problems showed a small to moderate improvement after dCBT relative to control.</s><s xml:id="_W4AyV9C">A significant but small effect in terms of reduced absenteeism attributed to poor sleep and increased job satisfaction was observed at week 24.</s><s xml:id="_r2CcZjJ">There were no significant effects at any time point on relationship functioning (RAS).</s><s xml:id="_DyMuA43">Mediation analyses indicated that changes in insomnia symptoms also accounted for significant and size-  able proportions of effects on these secondary outcomes at both week 8 and week 24 (eTable 3 in Supplement 2, RQ 4).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_rB6gp6R">Reported Adverse Effects</head><p xml:id="_TjgxrjX"><s xml:id="_RCZRVFA">There was 1 serious adverse event reported, which was unrelated to the intervention.</s><s xml:id="_gRdMn9v">The event was reported to the Uni-versity of Oxford Medical Sciences Inter-Divisional Ethics Committee.</s><s xml:id="_jyVWykF">Participants who received dCBT reported a higher occurrence of difficulty remembering things, headache and/or migraine, fatigue and/or exhaustion, extreme sleepiness, difficulty with concentration and attention, reduced motivation</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_4Ewv76q">Discussion</head><p xml:id="_WBHqEyS"><s xml:id="_KZunAPA">It is well established that CBT is the first-line treatment for people with chronic insomnia <ref type="bibr" target="#b13">14,</ref><ref type="bibr" target="#b16">[17]</ref><ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b20">21,</ref><ref type="bibr" target="#b21">22</ref> and that sleeprelated outcomes, whether on index measures of insomnia or on derivations from sleep diaries, show sustained improvement. <ref type="bibr" target="#b16">17</ref> Th</s><s xml:id="_u3rbTca"> findings from this study confirm large effects on insomnia symptoms.</s><s xml:id="_rBszwV5">However, we primarily addressed whether CBT for insomnia affects functional health, psychological well-being, and sleep-related quality of life.</s><s xml:id="_YfnkZwG">We used dCBT instead of face-to-face CBT to facilitate an adequately powered scientific inquiry of explanatory processes.</s></p><p xml:id="_Z3Gv2fT"><s xml:id="_mQbbWkQ">Our findings provide strong support for the hypothesis that dCBT improved participants' functional health relative to sleep hygiene education.</s><s xml:id="_q5EvWs9">At 24 weeks, effect sizes were small for functional health and psychological well-being (Cohen d, 0.31 and 0.38) and large for sleep-related quality of life (Cohen d, -1.46).</s><s xml:id="_VXKHFEG">The greater effect on sleep-related quality of life, measured with the GSII, likely occurs because the GSII specifically asks participants to define areas of impairment attributed to poor sleep, whereas functional health and well-being were assessed with global measures (PROMIS-10 and WEMWBS).</s><s xml:id="_Y73ecDb">Improvements in all 3 primary outcomes were mediated by insomnia improvements associated with dCBT.</s><s xml:id="_8KEkBRs">These mediation effects were substantial: 51% mediation of functional health, 47% of well-being, and 46% of sleep-related quality of life at 8 weeks, and 84% of functional health, 75% of wellbeing, and 66% of sleep-related quality of life at 24 weeks' follow-up.</s><s xml:id="_9JGMaBe">To our knowledge, this is the first large-scale study demonstrating a causal relationship between CBT-mediated reduction in insomnia symptoms and perceived health status and quality of life.</s></p><p xml:id="_U3tBWVs"><s xml:id="_XtnUHF9">A report of a parallel study (Oxford Access for Students Improving Sleep [OASIS]) exploring mental health symptoms as the outcome variable of interest and likewise demonstrated a causal relationship between insomnia improvement and reductions in mental health symptoms. <ref type="bibr" target="#b32">33</ref></s><s xml:id="_szVRPmR">Together, the mediation analyses in these 2 studies (with a total of 5466 participants) provide novel and convincing evidence that insomnia may be a legitimate and important target for mental health and well-being.</s><s xml:id="_42MQ8qm">Consideration of the secondary variables in the present study yields further data on the generalized effects of in-somnia improvement on symptoms of depression, anxiety, fatigue, sleepiness, and cognitive failures and productivity, with mediation in substantial part through changes in insomnia.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_pyyJmVR">Limitations</head><p xml:id="_zpQgmYD"><s xml:id="_aBN63zm">We are mindful of limitations of this research.</s><s xml:id="_ynsKZur">Although participant demographic characteristics were typical of clinical populations (eg, typically female, middle-aged) and had some similar characteristics (eg, two-thirds reported diagnosed health comorbidities), participants were not drawn from patient groups or health care services and therefore reflect individuals who experience insomnia in the general population.</s><s xml:id="_AnMPabR">This difference may reduce the generalizability to the insomnia patient group but increases the generalizability to those experiencing insomnia symptoms in the general population.</s><s xml:id="_BCWbU8v">As is typical of digital programs, and indeed of CBT in general, there was a substantial dropout from treatment (58% of participants completed ≥4 dCBT sessions); however, intentionto-treat analyses still identified significant improvements.</s><s xml:id="_6AMhxpS">Sensitivity and missing data analyses did not change the study conclusions.</s><s xml:id="_UAcPtQX">In addition, the instrument used to measure insomnia symptoms includes items around daytime functioning because these items are part of the DSM-5 insomnia disorder diagnosis; these items may have inflated the mediation effects.</s><s xml:id="_qr8a6ZN">Finally, we note that attributed adverse effects were more common in the group receiving dCBT than in the control participants.</s><s xml:id="_8nAn5hD">Despite widespread generalized benefits, dCBT can have adverse effects; we hypothesize that these effects might result from the sleep restriction component that is introduced in week 3. Potentially, these adverse effects were short lived; at weeks 8 and 24, sleepiness, fatigue, cognitive failures, and mood symptoms were more common in participants receiving SHE than in those receiving dCBT.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_Xp7fjBP">Conclusions</head><p xml:id="_pBxfxws"><s xml:id="_Se2fxcv">The results of this definitive trial suggest that dCBT not only is effective in improving insomnia symptoms but also demonstrates positive effects around the clock by improving the functional health, psychological well-being, and sleeprelated quality of life of people with positive screening results for insomnia disorder.</s><s xml:id="_tDHDRdy">In addition, improved insomnia is a mediator of these benefits.</s><s xml:id="_r3Ktw8W">These findings indicate that dCBT improves both daytime and nighttime aspects of insomnia, lending further weight to the clinical guideline recommendation of CBT as the treatment of choice for insomnia.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure</head><figDesc><div><p xml:id="_nmNfTAg"><s xml:id="_VPZpq6h">Figure.</s><s xml:id="_WF89KTn">Trial Design for the Digital Insomnia Therapy to Assist Your Life as Well as Your Sleep (DIALS) Study</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>( 9 -</head><label>9</label><figDesc><div><p xml:id="_gSS5vaH"><s xml:id="_nHqGk5S">item Patient Health Questionnaire<ref type="bibr" target="#b54">55</ref> [PHQ-9]; scale, 0-3; range: 0-27, and the 7-item Generalized Anxiety Disorder 56 [GAD-7]; scale, 0-3; range: 0-21), energy (7-item Flinders Fatigue Scale<ref type="bibr" target="#b56">57</ref> [FFS]; scale, 0-4; range: 0-28), relationship satisfaction (7-item Relationship Assessment Scale<ref type="bibr" target="#b57">58</ref> [RAS]; scale, 1-5; range: 7-35), cognitive functioning (25-item Cognitive Failures Questionnaire 59 [CFQ]; scale, 0-4; range: 0-100), work performance and satisfaction (Work Productivity and Activity Impairment questionnaire: Specific Health Problem 60 [WPAI:</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_pdwsmua"><s xml:id="_AEVWQxW">Descriptive Characteristics</s></p></div></figDesc><table><row><cell></cell><cell>SHE + TAU</cell><cell>dCBT + TAU</cell></row><row><cell>Characteristic</cell><cell>(n = 858)</cell><cell>(n = 853)</cell></row><row><cell>Demographic</cell><cell></cell><cell></cell></row><row><cell>Age, mean (SD), y</cell><cell>47.7 (13.6)</cell><cell>48.4 (13.9)</cell></row><row><cell>Sex, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Women</cell><cell>675 (78.7)</cell><cell>654 (76.7)</cell></row><row><cell>Men</cell><cell>183 (21.3)</cell><cell>199 (23.3)</cell></row><row><cell>Ethnic origin, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Asian</cell><cell>24 (2.8)</cell><cell>21 (2.5)</cell></row><row><cell>Black</cell><cell>12 (1.4)</cell><cell>7 (0.8)</cell></row><row><cell>Mixed</cell><cell>16 (1.9)</cell><cell>20 (2.3)</cell></row><row><cell>Other</cell><cell>23 (2.7)</cell><cell>12 (1.4)</cell></row><row><cell>White</cell><cell>773 (90.1)</cell><cell>785 (92.0)</cell></row><row><cell>Do not wish to state</cell><cell>9 (1.0)</cell><cell>8 (0.9)</cell></row><row><cell>Continuous full education, mean</cell><cell>16.6 (3.5)</cell><cell>16.5 (3.9)</cell></row><row><cell>(SD), y</cell><cell></cell><cell></cell></row><row><cell>Employment, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Full-time employed</cell><cell>411 (47.9)</cell><cell>393 (46.2)</cell></row><row><cell>Part-time employed</cell><cell>187 (21.8)</cell><cell>161 (18.9)</cell></row><row><cell>Unemployed</cell><cell>34 (4.0)</cell><cell>40 (4.7)</cell></row><row><cell>Retired</cell><cell>149 (16.2)</cell><cell>152 (17.7)</cell></row><row><cell>Full-time student</cell><cell>32 (3.7)</cell><cell>46 (5.4)</cell></row><row><cell>Full-time homemaker or carer</cell><cell>52 (6.0)</cell><cell>56 (6.6)</cell></row><row><cell>Partner, No. (%)</cell><cell></cell><cell></cell></row><row><cell>No</cell><cell>240 (28.0)</cell><cell>213 (25.0)</cell></row><row><cell>Yes, living apart</cell><cell>64 (7.4)</cell><cell>76 (8.9)</cell></row><row><cell>Yes, living together</cell><cell>553 (64.5)</cell><cell>560 (65.7)</cell></row><row><cell>Lifestyle</cell><cell></cell><cell></cell></row><row><cell>Caffeine consumption, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Never</cell><cell>106 (12.1)</cell><cell>81 (9.5)</cell></row><row><cell>Less than once per day</cell><cell>114 (13.3)</cell><cell>111 (13.0)</cell></row><row><cell>Once per day</cell><cell>197 (23.0)</cell><cell>204 (23.9)</cell></row><row><cell>2-3 Times per day</cell><cell>305 (35.6)</cell><cell>330 (38.7)</cell></row><row><cell>≥4 Times per day</cell><cell>134 (15.6)</cell><cell>124 (14.5)</cell></row><row><cell>Alcohol consumption, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Never</cell><cell>200 (23.3)</cell><cell>205 (24.0)</cell></row><row><cell>Less than once per week</cell><cell>183 (21.3)</cell><cell>154 (18.1)</cell></row><row><cell>Once per week</cell><cell>116 (13.5)</cell><cell>127 (14.9)</cell></row><row><cell>2-3 Times per week</cell><cell>223 (26.0)</cell><cell>221 (25.9)</cell></row><row><cell>≥4 Times per week</cell><cell>135 (15.7)</cell><cell>145 (17.0)</cell></row><row><cell>Smoking, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Never</cell><cell>483 (54.9)</cell><cell>481 (56.6)</cell></row><row><cell>Previously</cell><cell>309 (36.0)</cell><cell>297 (34.8)</cell></row><row><cell>Rarely</cell><cell>29 (3.4)</cell><cell>31 (3.6)</cell></row><row><cell>1-10 per day</cell><cell>19 (2.2)</cell><cell>28 (3.3)</cell></row><row><cell>11-20 per day</cell><cell>19 (2.2)</cell><cell>13 (1.5)</cell></row><row><cell>≥21 per day</cell><cell>8 (0.9)</cell><cell>0</cell></row><row><cell>Exercising, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Never</cell><cell>85 (9.9)</cell><cell>77 (9.0)</cell></row><row><cell>Less than once per week</cell><cell>111 (12.9)</cell><cell>85 (10.0)</cell></row><row><cell>Once per week</cell><cell>134 (15.6)</cell><cell>136 (15.9)</cell></row><row><cell>2-3 Times per week</cell><cell>279 (32.5)</cell><cell>317 (37.2)</cell></row><row><cell>≥4 Times per week</cell><cell>247 (28.8)</cell><cell>237 (27.8)</cell></row><row><cell></cell><cell></cell><cell>(continued)</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 1 .</head><label>1</label><figDesc><div><p xml:id="_xFEzWPm"><s xml:id="_SJCTS4E">Descriptive Characteristics (continued)</s></p></div></figDesc><table><row><cell></cell><cell>SHE + TAU</cell><cell>dCBT + TAU</cell></row><row><cell>Characteristic</cell><cell>(n = 858)</cell><cell>(n = 853)</cell></row><row><cell>Health</cell><cell></cell><cell></cell></row><row><cell>BMI, mean (SD)</cell><cell>25.3 (6.0)</cell><cell>25.1 (5.1)</cell></row><row><cell>Medical diagnosis, No. (%)</cell><cell></cell><cell></cell></row><row><cell>Heart disease or high blood</cell><cell>106 (12.4)</cell><cell>106 (12.4)</cell></row><row><cell>pressure</cell><cell></cell><cell></cell></row><row><cell>Diabetes</cell><cell>18 (2.1)</cell><cell>18 (2.1)</cell></row><row><cell>Stroke or other neurological</cell><cell>8 (0.9)</cell><cell>16 (1.9)</cell></row><row><cell>problems</cell><cell></cell><cell></cell></row><row><cell>Cancer</cell><cell>41 (4.8)</cell><cell>39 (4.6)</cell></row><row><cell>Arthritis/other joint problems</cell><cell>90 (10.5)</cell><cell>87 (10.2)</cell></row><row><cell>Digestive disorders</cell><cell>121 (13.9)</cell><cell>123 (14.4)</cell></row><row><cell>Depression or anxiety</cell><cell>333 (38.8)</cell><cell>317 (37.2)</cell></row><row><cell>Hormonal problems</cell><cell>57 (6.6)</cell><cell>70 (8.2)</cell></row><row><cell>Other comorbidity</cell><cell>115 (13.4)</cell><cell>127 (14.9)</cell></row><row><cell>Any diagnosis</cell><cell>570 (66.4)</cell><cell>561 (65.8)</cell></row><row><cell>Prescribed sleep medication, mean</cell><cell>1.6 (3.4)</cell><cell>1.6 (3.7)</cell></row><row><cell>(SD), No. of nights per 14 d</cell><cell></cell><cell></cell></row><row><cell>Nonprescribed sleeping</cell><cell>2.3 (3.9)</cell><cell>2.2 (3.9)</cell></row><row><cell>medication, mean (SD), No. of</cell><cell></cell><cell></cell></row><row><cell>nights per 14 d</cell><cell></cell><cell></cell></row><row><cell>Outcomes at baseline, mean (SD) a</cell><cell></cell><cell></cell></row><row><cell>Functional health (PROMIS-10)</cell><cell></cell><cell></cell></row><row><cell>Total</cell><cell>31.8 (5.6)</cell><cell>31.8 (5.8)</cell></row><row><cell>Physical</cell><cell>14.3 (2.2)</cell><cell>14.4 (2.3)</cell></row><row><cell>Mental</cell><cell>11.4 (3.0)</cell><cell>11.2 (3.0)</cell></row><row><cell>Mental well-being (WEMWBS)</cell><cell>43.2 (7.9)</cell><cell>43.1 (7.7)</cell></row><row><cell>Sleep-related quality of life (GSII)</cell><cell></cell><cell></cell></row><row><cell>Most important concern</cell><cell>87.3 (12.7)</cell><cell>87.8 (12.8)</cell></row><row><cell>Second most important concern</cell><cell>75.4 (16.4)</cell><cell>76.3 (17.3)</cell></row><row><cell>Third most important concern</cell><cell>60.2 (21.3)</cell><cell>60.9 (21.4)</cell></row><row><cell>Combined score</cell><cell>222.9 (44.5)</cell><cell>224.9 (45.9)</cell></row><row><cell>Insomnia (SCI)</cell><cell>6.6 (3.3)</cell><cell>6.5 (3.2)</cell></row><row><cell>Depressive symptoms (PHQ-9)</cell><cell>9.7 (4.2)</cell><cell>9.8 (4.1)</cell></row><row><cell>Anxiety symptoms (GAD-7)</cell><cell>7.4 (4.7)</cell><cell>7.4 (4.7)</cell></row><row><cell>Sleepiness (ESS)</cell><cell>6.2 (4.5)</cell><cell>6.1 (4.4)</cell></row><row><cell>Fatigue (FFS)</cell><cell>19.1 (5.4)</cell><cell>19.0 (5.5)</cell></row><row><cell>Relationship satisfaction (RAS)</cell><cell>27.6 (5.8)</cell><cell>27.8 (5.8)</cell></row><row><cell>Cognitive functioning (CFQ)</cell><cell>42.5 (16.8)</cell><cell>43.1 (15.4)</cell></row><row><cell>Work productivity and impairment,</cell><cell></cell><cell></cell></row><row><cell>mean (SD), WPAI</cell><cell></cell><cell></cell></row><row><cell>Presenteeism</cell><cell>41.0 (23.2)</cell><cell>42.2 (24.0)</cell></row><row><cell>Absenteeism</cell><cell>8.03 (16.9)</cell><cell>7.38 (16.3)</cell></row><row><cell cols="3">Abbreviations: BMI, body mass index (calculated as weight in kilograms divided</cell></row><row><cell cols="3">by height in meters squared); CFQ, Cognitive Failures Questionnaire; dCBT,</cell></row><row><cell cols="3">digital cognitive behavioral therapy; ESS, Epworth Sleepiness Scale; FFS,</cell></row><row><cell cols="3">Flinders Fatigue Scale; GAD-7, 7-item Generalized Anxiety Disorder; GSII,</cell></row><row><cell cols="3">Glasgow Sleep Impact Index; PHQ-9, 9-item Patient Health Questionnaire;</cell></row><row><cell cols="3">PROMIS-10, 10-item Patient-Reported Outcomes Measurement Information</cell></row><row><cell cols="3">System; RAS, Relationship Assessment Scale; SCI, 8-item Sleep Condition</cell></row><row><cell cols="3">Indicator; SHE, sleep hygiene education; TAU, treatment as usual; WEMWBS,</cell></row><row><cell cols="3">Warwick-Edinburgh Mental Well-being Scale; WPAI, Work Productivity and</cell></row><row><cell>Activity Impairment questionnaire.</cell><cell></cell><cell></cell></row></table><note xml:id="_jphYksa"><p><s xml:id="_U7CKXWn">a Outcome assessment scales are explained in the Measurements subsection of the Methods section.</s><s xml:id="_BFtCca5">Effect of Digital Cognitive Behavioral Therapy for Insomnia on Measures of Health and Well-being Original Investigation Research jamapsychiatry.com</s><s xml:id="_TWSrP5S">(Reprinted) JAMA Psychiatry January 2019 Volume 76, Number 1 8, 0.31; and week 24, 0.31) and mental well-being (Cohen d for week 4, 0.13; week 8, 0.35; and week 24, 0.38), and a significant reduction in sleep-related impairment to quality of life (Cohen d for week 4, -0.69; week 8, -1.38; and week 24, -1.46; RQ 1 [Table 2]).</s><s xml:id="_V8YQqWQ">Effects were robust across sensitivity analyses investigating assumptions regarding missingness of the outcome.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 2 .</head><label>2</label><figDesc><div><p xml:id="_ycZ7W4z"><s xml:id="_Z7WxZhn">Effects of Digital Cognitive Behavioral Therapy vs Sleep Hygiene Education on Primary Outcomes: Physical Health, Psychological Well-being, Sleep-Related Quality of Life, and Insomnia</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Unadjusted, Mean (SD)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Assessment a</cell><cell>SHE + TAU</cell><cell>dCBT + TAU</cell><cell>Adjusted Difference (95% CI)</cell><cell>Cohen d</cell><cell>PValue</cell><cell></cell></row><row><cell>PROMIS-10</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>32.52 (6.05)</cell><cell>33.84 (6.49)</cell><cell>0.90 (0.40 to 1.40)</cell><cell>0.16</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 8</cell><cell>32.92 (6.18)</cell><cell>35.08 (6.65)</cell><cell>1.76 (1.24 to 2.28)</cell><cell>0.31</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24 WEMWBS</cell><cell>33.10 (6.10)</cell><cell>35.24 (6.88)</cell><cell>1.76 (1.22 to 2.30)</cell><cell>0.31</cell><cell>&lt;.001</cell><cell>Abbreviations: dCBT, digital cognitive behavioral therapy; GSII, Glasgow Sleep Impact Index; 10-item</cell></row><row><cell>Week 4</cell><cell>44.72 (8.21)</cell><cell>46.03 (8.55)</cell><cell>1.04 (0.28 to 1.80)</cell><cell>0.13</cell><cell>.007</cell><cell>Patient-Reported Outcomes</cell></row><row><cell>Week 8 Week 24</cell><cell>45.16 (8.77) 45.31 (8.89)</cell><cell>48.12 (8.82) 48.62 (9.02)</cell><cell>2.68 (1.89 to 3.47) 2.95 (2.13 to 3.76)</cell><cell>0.35 0.38</cell><cell>&lt;.001 &lt;.001</cell><cell>Measure; SHE, sleep hygiene education; TAU, treatment as usual; WEMWBS, Warwick-Edinburgh</cell></row><row><cell>GSII b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>Mental Well-being Scale.</cell></row><row><cell>Week 4</cell><cell>69.80 (23.64)</cell><cell>60.69 (26.20)</cell><cell>-8.76 (-11.83 to -5.69)</cell><cell>-0.69</cell><cell>&lt;.001</cell><cell>a Outcome assessment scales are</cell></row><row><cell>Week 8</cell><cell>65.68 (25.86)</cell><cell>46.78 (29.90)</cell><cell>-17.60 (-20.81 to -14.39)</cell><cell>-1.38</cell><cell>&lt;.001</cell><cell>explained in the Measurements subsection of the Methods section.</cell></row><row><cell>Week 24</cell><cell>63.33 (27.26)</cell><cell>43.78 (31.25)</cell><cell>-18.72 (-22.04 to -15.41)</cell><cell>-1.46</cell><cell>&lt;.001</cell><cell></cell></row></table><note xml:id="_hReNpUX"><p><s xml:id="_kycApww">b Highest-ranked impairment.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 3 .</head><label>3</label><figDesc><div><p xml:id="_sukayFC"><s xml:id="_ta8uEUn">Mediation Effects of Insomnia Improvement on Primary Outcomes: Physical Health, Mental Well-being, Sleep-Related Impact, and Insomnia</s></p></div></figDesc><table><row><cell></cell><cell></cell><cell>Total Effect</cell><cell></cell><cell>Direct Effect</cell><cell></cell><cell>Indirect Effect</cell><cell></cell><cell>Mediation,</cell></row><row><cell>Asssessment a</cell><cell>Mediation Tested</cell><cell>Effect Size (SE)</cell><cell>P Value</cell><cell>Effect Size (SE)</cell><cell>P Value</cell><cell>Effect Size (SE)</cell><cell>P Value</cell><cell>%</cell></row><row><cell>PROMIS-10</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 8</cell><cell>SCI week 4</cell><cell>1.76 (0.26)</cell><cell>&lt;.001</cell><cell>0.65 (0.27)</cell><cell>.02</cell><cell>0.89 (0.12)</cell><cell>&lt;.001</cell><cell>50.5</cell></row><row><cell>Week 24</cell><cell>SCI week 8</cell><cell>1.75 (0.27)</cell><cell>&lt;.001</cell><cell>0.13 (0.29)</cell><cell>.66</cell><cell>1.47 (0.14)</cell><cell>&lt;.001</cell><cell>83.8</cell></row><row><cell>WEMWBS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 8</cell><cell>SCI week 4</cell><cell>2.67 (0.40)</cell><cell>&lt;.001</cell><cell>1.21 (0.42)</cell><cell>.004</cell><cell>1.26 (0.17)</cell><cell>&lt;.001</cell><cell>47.0</cell></row><row><cell>Week 24</cell><cell>SCI week 8</cell><cell>2.93 (0.41)</cell><cell>&lt;.001</cell><cell>0.76 (0.45)</cell><cell>.09</cell><cell>2.17 (0.20)</cell><cell>&lt;.001</cell><cell>74.9</cell></row><row><cell>GSII b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 8</cell><cell>SCI week 4</cell><cell>-17.54 (1.63)</cell><cell>&lt;.001</cell><cell>-8.69 (1.60)</cell><cell>&lt;.001</cell><cell>-7.98 (0.93)</cell><cell>&lt;.001</cell><cell>45.5</cell></row><row><cell>Week 24</cell><cell>SCI week 8</cell><cell>-18.63 (1.68)</cell><cell>&lt;.001</cell><cell>-7.84 (1.68)</cell><cell>&lt;.001</cell><cell>-12.27 (0.84)</cell><cell>&lt;.001</cell><cell>65.9</cell></row></table><note xml:id="_JGDgSaf"><p><s xml:id="_V6FCjV2">Abbreviations: GSII, Glasgow Sleep Impact Index; PROMIS-10, 10-item Patient-Reported Outcomes Measure; SCI, Sleep Condition Indicator; WEMWBS, Warwick-Edinburgh Mental Well-being Scale.</s><s xml:id="_Xqdczev">a Outcome assessment scales are explained in the Measurements subsection of the Methods section.</s><s xml:id="_yCRTkTb">b Highest-ranked impairment.</s></p></note></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_5"><head>Table 4 .</head><label>4</label><figDesc><div><p xml:id="_mPspQsj"><s xml:id="_pc3PdMM">Effects of dCBT vs SHE on Mediator and Secondary Outcomes of Mood, Fatigue, Relationship, Cognition, Work Performance, and Sleepiness Effect of Digital Cognitive Behavioral Therapy for Insomnia on Measures of Health and Well-being Original Investigation Research /or energy, and irritability attributed to the insomnia improvement program at week 8 (eTable 4 in Supplement 2).</s></p></div></figDesc><table><row><cell></cell><cell cols="2">Unadjusted, Mean (SE)</cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Assessment a</cell><cell>SHE + TAU</cell><cell>dCBT + TAU</cell><cell>Adjusted Difference (95% CI)</cell><cell>Cohen d</cell><cell>PValue</cell><cell></cell></row><row><cell>SCI b</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>9.96 (4.70)</cell><cell>13.00 (5.01)</cell><cell>2.88 (2.28 to 3.48)</cell><cell>0.89</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 8</cell><cell>11.05 (5.32)</cell><cell>16.29 (6.17)</cell><cell>4.90 (4.28 to 5.53)</cell><cell>1.51</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>11.66 (5.84)</cell><cell>16.89 (6.91)</cell><cell>4.91 (4.27 to 5.56)</cell><cell>1.51</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>PHQ-9</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>8.36 (4.38)</cell><cell>7.47 (4.26)</cell><cell>-0.72 (-1.15 to -0.29)</cell><cell>-0.17</cell><cell>.001</cell><cell></cell></row><row><cell>Week 8</cell><cell>8.16 (4.90)</cell><cell>6.22 (4.40)</cell><cell>-1.59 (-2.04 to -1.14)</cell><cell>-0.38</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>7.94 (4.58)</cell><cell>6.13 (4.59)</cell><cell>-1.58 (-2.05 to -1.12)</cell><cell>-0.38</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>GAD-7</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>6.23 (4.52)</cell><cell>5.51 (4.18)</cell><cell>-0.49 (-0.91 to -0.06)</cell><cell>-0.10</cell><cell>.03</cell><cell></cell></row><row><cell>Week 8</cell><cell>6.10 (4.69)</cell><cell>4.68 (4.21)</cell><cell>-1.19 (-1.63 to -0.74)</cell><cell>-0.25</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>6.05 (4.50)</cell><cell>4.70 (4.21)</cell><cell>-1.10 (-1.56 to -0.64)</cell><cell>-0.24</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>ESS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>6.41 (4.64)</cell><cell>5.55 (4.34)</cell><cell>-0.52 (-0.88 to -0.17)</cell><cell>-0.12</cell><cell>.003</cell><cell></cell></row><row><cell>Week 8</cell><cell>6.14 (4.62)</cell><cell>4.81 (3.94)</cell><cell>-1.01 (-1.38 to -0.64)</cell><cell>-0.23</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>6.24 (4.61)</cell><cell>4.67 (3.97)</cell><cell>-1.41 (-1.79 to -1.03)</cell><cell>-0.32</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>FFS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>16.93 (5.87)</cell><cell>14.82 (5.96)</cell><cell>-2.01 (-2.63 to -1.39)</cell><cell>-0.37</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 8</cell><cell>15.91 (6.08)</cell><cell>11.84 (6.54)</cell><cell>-3.83 (-4.48 to -3.19)</cell><cell>-0.71</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>15.67 (6.46)</cell><cell>11.41 (6.64)</cell><cell>-4.06 (-4.72 to -3.39)</cell><cell>-0.75</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>RAS</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>24.45 (7.44)</cell><cell>24.98 (7.78)</cell><cell>0.12 (-0.38 to 0.62)</cell><cell>0.02</cell><cell>.64</cell><cell></cell></row><row><cell>Week 8</cell><cell>24.36 (7.50)</cell><cell>25.23 (7.64)</cell><cell>0.07 (-0.44 to 0.59)</cell><cell>0.01</cell><cell>.79</cell><cell></cell></row><row><cell>Week 24</cell><cell>24.72 (7.42)</cell><cell>25.45 (7.83)</cell><cell>0.01 (-0.53 to 0.54)</cell><cell>0.00</cell><cell>.98</cell><cell></cell></row><row><cell>CFQ</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>41.79 (16.79)</cell><cell>39.53 (15.54)</cell><cell>-2.08 (-3.23 to -0.92)</cell><cell>-0.13</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 8</cell><cell>41.19 (16.97)</cell><cell>36.93 (16.44)</cell><cell>-4.18 (-5.38 to -2.99)</cell><cell>-0.26</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>41.25 (16.49)</cell><cell>37.47 (15.47)</cell><cell>-3.38 (-4.60 to -2.16)</cell><cell>-0.21</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>WPAI presenteeism</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell></row><row><cell>Week 4</cell><cell>33.61 (23.82)</cell><cell>31.26 (23.52)</cell><cell>-2.27 (-5.47 to 0.92)</cell><cell>-0.10</cell><cell>.16</cell><cell></cell></row><row><cell>Week 8</cell><cell>32.71 (23.32)</cell><cell>23.56 (21.21)</cell><cell>-9.55 (-12.89 to -6.21)</cell><cell>-0.41</cell><cell>&lt;.001</cell><cell></cell></row><row><cell>Week 24</cell><cell>32.08 (23.37)</cell><cell>20.56 (20.69)</cell><cell>-9.94 (-13.42 to -6.46)</cell><cell>-0.42</cell><cell>&lt;.001</cell><cell>Abbreviations: CFQ, Cognitive</cell></row><row><cell>WPAI absenteeism Week 4</cell><cell>2.56 (8.94)</cell><cell>3.22 (9.87)</cell><cell>0.39 (-1.31 to 2.10)</cell><cell>0.02</cell><cell>.65</cell><cell>Failures Questionnaire; dCBT, digital cognitive behavioral therapy; ESS, Epworth Sleepiness Scale; FFS,</cell></row><row><cell>Week 8</cell><cell>3.54 (11.59)</cell><cell>2.34 (8.26)</cell><cell>-1.23 (-3.02 to -0.56)</cell><cell>-0.07</cell><cell>.18</cell><cell>Flinders Fatigue Scale; GAD-7, 7-item</cell></row><row><cell>Week 24 Job satisfaction</cell><cell>4.61 (14.01)</cell><cell>3.41 (12.16)</cell><cell>-2.09 (-3.95 to -0.23)</cell><cell>-0.13</cell><cell>.03</cell><cell>Generalized Anxiety Disorder; PHQ-9, 9-item Patient Health Questionnaire; RAS, Relationship Assessment Scale,</cell></row><row><cell>Week 4</cell><cell>3.48 (2.14)</cell><cell>3.30 (2.10)</cell><cell>-0.05 (-0.22 to 0.12)</cell><cell>-0.02</cell><cell>.58</cell><cell>SCI, Sleep Condition Indicator; SHE,</cell></row><row><cell>Week 8 Week 24</cell><cell>3.45 (2.07) 3.49 (2.05)</cell><cell>3.43 (2.14) 3.58 (2.16)</cell><cell>0.08 (-0.09 to 0.26) 0.27 (0.09 to 0.45)</cell><cell>0.08 0.27</cell><cell>.36 .004</cell><cell>sleep hygiene education; TAU, treatment as usual; WPAI, Work Productivity and Activity Impairment</cell></row><row><cell>Life satisfaction</cell><cell></cell><cell></cell><cell></cell><cell></cell><cell></cell><cell>questionnaire.</cell></row><row><cell>Week 4</cell><cell>2.84 (0.72)</cell><cell>2.90 (0.72)</cell><cell>0.07 (-0.02 to 0.13)</cell><cell>0.10</cell><cell>.06</cell><cell>a Outcome assessment scales are</cell></row><row><cell>Week 8</cell><cell>2.86 (0.70)</cell><cell>2.96 (0.73)</cell><cell>0.12 (0.05 to 0.19)</cell><cell>0.18</cell><cell>&lt;.001</cell><cell>explained in the Measurements subsection of the Methods section.</cell></row><row><cell>Week 24</cell><cell>2.86 (0.70)</cell><cell>3.01 (0.74)</cell><cell>0.16 (0.09 to 0.24)</cell><cell>0.24</cell><cell>&lt;.001</cell><cell>b Highest-ranked impairment.</cell></row></table><note xml:id="_TQQh2Qh"><p>jamapsychiatry.com (Reprinted) JAMA Psychiatry January 2019 Volume 76, Number 1 7 jamanetwork/2019/psy/jan2019/yoi180074 PAGE: right 7 SESS: 60 OUTPUT: Sep 14 10:55 2018 © 2018 American Medical Association. All rights reserved.</p><p><s xml:id="_8b4eMgm">and</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p xml:id="_h5gRumn"><s xml:id="_FUGRhpd">jamanetwork/2019/psy/jan2019/yoi180074 PAGE: left 4 SESS: 60 OUTPUT: Sep 14 10:55 2018 © 2018 American Medical Association.</s><s xml:id="_YXsP3Sk">All rights reserved.</s></p></note>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_1"><p xml:id="_Ey2s3Bf"><s xml:id="_8Q7s5TW">JAMA Psychiatry January 2019 Volume 76, Number 1 (Reprinted) jamapsychiatry.com</s></p></note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_d8jdEYj"><p xml:id="_PEjCdGt"><s xml:id="_5SrnB3Y">Author Contributions: Dr Espie had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.</s><s xml:id="_7eQ372u">Concept and design: Espie, Kyle, Gordon, Drake, Siriwardena, Cape, Ong, Sheaves, Foster, Freeman, Costa-Font, Luik Role of the Funder/Sponsor: Big Health Ltd was involved in the design and conduct of the study; collection, management, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.</s><s xml:id="_nV5qBWe">The funder was not involved in the analysis of the data.</s><s xml:id="_jrhsT5q">Other funders had no role in the design and conduct of the study, collection of the data, data analysis, management, interpretation, or review or approval of the manuscript.</s><s xml:id="_sv2nswZ">Additional Contribution: Alasdair Henry, PhD, Big Health Ltd, helped with formatting the manuscript, which was performed as part of his regular duties; he was not additionally compensated.</s><s xml:id="_fGAc69m">Sleepio was provided to participants at no cost.</s><s xml:id="_aqtPc6u">The study was conducted at the University of Oxford, Sleep &amp; Circadian Neuroscience Institute.</s><s xml:id="_E5jYVqq">The University of Oxford has a memorandum of understanding with Big Health for the conduct of joint research.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head xml:id="_NZDaUY5">Disclaimer</head></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<idno type="DOI">10.1176/appi.books.9780890425596</idno>
		<title level="m" xml:id="_SURzFDW">Diagnostic and Statistical Manual of Mental Disorders</title>
		<meeting><address><addrLine>Arlington, VA</addrLine></address></meeting>
		<imprint>
			<publisher>American Psychiatric Association</publisher>
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>American Psychiatric Association 5th ed</note>
	<note type="raw_reference">American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_KkYa4up">Epidemiology of insomnia: what we know and what we still need to learn</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Ohayon</surname></persName>
		</author>
		<idno type="DOI">10.1053/smrv.2002.0186</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fzQzwqK">Sleep Med Rev</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="97" to="111" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev. 2002;6(2):97-111. doi:10.1053/smrv.2002.0186</note>
</biblStruct>

<biblStruct xml:id="b2">
	<monogr>
		<title level="m" type="main" xml:id="_7YTADKF">Epidemiology of Sleep: Age, Gender, and Ethnicity</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Lichstein</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2004">2004</date>
			<publisher>Lawrence Erlbaum Assoc</publisher>
			<pubPlace>Mahwah, NJ</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Lichstein KL. Epidemiology of Sleep: Age, Gender, and Ethnicity. Mahwah, NJ: Lawrence Erlbaum Assoc; 2004.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_Uv5vUgf">Epidemiology of insomnia: a longitudinal study in a UK population</title>
		<author>
			<persName><forename type="first">H</forename><surname>Morphy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lewis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Boardman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Croft</surname></persName>
		</author>
		<idno type="DOI">10.1093/sleep/30.3.274</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_T2vXpcs">Sleep</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="274" to="280" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR. Epidemiology of insomnia: a longitudinal study in a UK population. Sleep. 2007;30(3):274-280.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main" xml:id="_t4hxbs9">Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Pigeon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Bishop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Krueger</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11920-017-0802-x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_mfegxGJ">Curr Psychiatry Rep</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page">44</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pigeon WR, Bishop TM, Krueger KM. Insomnia as a precipitating factor in new onset mental illness: a systematic review of recent findings. Curr Psychiatry Rep. 2017;19(8):44. doi:10.1007/s11920- 017-0802-x</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_eSAAaAc">The effects of insomnia and sleep loss on cardiovascular disease</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Aouad</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jsmc.2017.01.005</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Ua5Ycuk">Sleep Med Clin</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="167" to="177" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Khan MS, Aouad R. The effects of insomnia and sleep loss on cardiovascular disease. Sleep Med Clin. 2017;12(2):167-177. doi:10.1016/j.jsmc.2017.01.005</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_gB7BS9A">Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Vgontzas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Liao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pejovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Calhoun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Karataraki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">O</forename><surname>Bixler</surname></persName>
		</author>
		<idno type="DOI">10.2337/dc09-0284</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ESAfBd8">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1980" to="1985" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Vgontzas AN, Liao D, Pejovic S, Calhoun S, Karataraki M, Bixler EO. Insomnia with objective short sleep duration is associated with type 2 diabetes: a population-based study. Diabetes Care. 2009;32(11):1980-1985. doi:10.2337/dc09-0284</note>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main" xml:id="_duFZ7Vb">Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Cappuccio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D'</forename><surname>Elia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Strazzullo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
		<idno type="DOI">10.2337/dc09-1124</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KnbzWNU">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="414" to="420" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cappuccio FP, D&apos;Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2010;33(2):414-420. doi:10.2337 /dc09-1124</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main" xml:id="_atwHk74">Insomnia and health-related quality of life</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.smrv.2009.07.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_wbtb66F">Sleep Med Rev</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="69" to="82" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010; 14(1):69-82. doi:10.1016/j.smrv.2009.07.004</note>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main" xml:id="_nzcWRWq">The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hames</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cyhlarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Benzeval</surname></persName>
		</author>
		<idno type="DOI">10.4088/jcp.12m07954</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hbFcg2x">J Clin Psychiatry</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="issue">12</biblScope>
			<biblScope unit="page" from="1478" to="e1484" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Kyle SD, Hames P, Cyhlarova E, Benzeval M. The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey. J Clin Psychiatry. 2012;73(12):e1478-e1484. doi:10.4088 /JCP.12m07954</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main" xml:id="_YfrV5zV">Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey: II</title>
		<author>
			<persName><forename type="first">T</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ancoli-</forename><surname>Israel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_qf9tAYN">Sleep</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">suppl 2</biblScope>
			<biblScope unit="page" from="354" to="S358" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Roth T, Ancoli-Israel S. Daytime consequences and correlates of insomnia in the United States: results of the 1991 National Sleep Foundation Survey: II. Sleep. 1999;22(suppl 2):S354-S358.</note>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main" xml:id="_7VGMMfN">Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Leblanc</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Daley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Gregoire</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Mérette</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.sleep.2005.08.008</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_zqPRwTA">Sleep Med</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="123" to="130" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morin CM, LeBlanc M, Daley M, Gregoire JP, Mérette C. Epidemiology of insomnia: prevalence, self-help treatments, consultations, and determinants of help-seeking behaviors. Sleep Med. 2006;7(2):123-130. doi:10.1016/j.sleep.2005.08.008</note>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main" xml:id="_hBMgnYW">Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians</title>
		<author>
			<persName><forename type="first">A</forename><surname>Qaseem</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kansagara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Forciea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Cooke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Denberg</surname></persName>
		</author>
		<idno type="DOI">10.7326/m15-2175</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ZbvpgP9">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">165</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="125" to="133" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD; Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2016;165(2):125-133. doi:10.7326/M15-2175</note>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main" xml:id="_rXc9M9y">European guideline for the diagnosis and treatment of insomnia</title>
		<author>
			<persName><forename type="first">D</forename><surname>Riemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Baglioni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Bassetti</surname></persName>
		</author>
		<idno type="DOI">10.1111/jsr.12594</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fdPpwuq">J Sleep Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="675" to="700" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riemann D, Baglioni C, Bassetti C, et al. European guideline for the diagnosis and treatment of insomnia. J Sleep Res. 2017;26(6):675-700. doi: 10.1111/jsr.12594</note>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main" xml:id="_e9p4eCF">British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Nutt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Alford</surname></persName>
		</author>
		<idno type="DOI">10.1177/0269881110379307</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_STsEbsh">J Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="issue">11</biblScope>
			<biblScope unit="page" from="1577" to="1601" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Wilson SJ, Nutt DJ, Alford C, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577-1601. doi:10.1177/0269881110379307</note>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main" xml:id="_v3gGty5">NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults</title>
		<idno type="DOI">10.1176/foc.7.4.foc538</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GXM2ncu">NIH Consens State Sci Statements</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="1" to="30" />
			<date type="published" when="2005">2005</date>
		</imprint>
		<respStmt>
			<orgName>National Institutes of Health</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">National Institutes of Health. NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens State Sci Statements. 2005;22(2):1-30.</note>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main" xml:id="_HxW977A">Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Van Straten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Van Der Zweerde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kleiboer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cuijpers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Lancee</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.smrv.2017.02.001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Z3qbCvU">Sleep Med Rev</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="3" to="16" />
			<date type="published" when="2018">2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin CM, Lancee J. Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep Med Rev. 2018;38:3-16. doi:10.1016/j.smrv.2017.02.001 doi:10.1016/j.smrv .2017.02.001</note>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main" xml:id="_egkjwW8">Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Mitchell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Gehrman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Perlis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Umscheid</surname></persName>
		</author>
		<idno type="DOI">10.1186/1471-2296-13-40</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_FJMfpks">BMC Fam Pract</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page">40</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Mitchell MD, Gehrman P, Perlis M, Umscheid CA. Comparative effectiveness of cognitive behavioral therapy for insomnia: a systematic review. BMC Fam Pract. 2012;13:40. doi:10.1186 /1471-2296-13-40</note>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main" xml:id="_w4ZcfWk">The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies</title>
		<author>
			<persName><forename type="first">D</forename><surname>Riemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Perlis</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.smrv.2008.06.001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uMDkMHY">Sleep Med Rev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="205" to="214" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Riemann D, Perlis ML. The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev. 2009;13(3):205-214. doi:10.1016/j.smrv.2008.06.001</note>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main" xml:id="_96GDXPs">Digital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science review</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Luik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40675-017-0065-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hSXqSHM">Curr Sleep Med Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="48" to="56" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Luik AI, Kyle SD, Espie CA. Digital cognitive behavioral therapy (dCBT) for insomnia: a state-of-the-science review. Curr Sleep Med Rep. 2017;3(2):48-56. doi:10.1007/s40675-017-0065-4</note>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main" xml:id="_szvfQFt">Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Seyffert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Lagisetty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Landgraf</surname></persName>
		</author>
		<idno type="DOI">10.1371/journal.pone.0149139</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_TqjTCXd">PLoS One</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">149139</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Seyffert M, Lagisetty P, Landgraf J, et al. Internet-delivered cognitive behavioral therapy to treat insomnia: a systematic review and meta-analysis. PLoS One. 2016;11(2):e0149139. doi: 10.1371/journal.pone.0149139</note>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main" xml:id="_PQuubPE">Efficacy of internet-delivered cognitive-behavioral therapy for insomnia-a systematic review and meta-analysis of randomized controlled trials</title>
		<author>
			<persName><forename type="first">R</forename><surname>Zachariae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Lyby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Ritterband</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O'</forename><surname>Toole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename></persName>
		</author>
		<idno type="DOI">10.1016/j.smrv.2015.10.004</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_b5xFdZq">Sleep Med Rev</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Zachariae R, Lyby MS, Ritterband LM, O&apos;Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia-a systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1-10. doi: 10.1016/j.smrv.2015.10.004</note>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main" xml:id="_CSDfWsn">Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Peoples</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Garland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Perlis</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11764-017-0597-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yWWrU2j">J Cancer Surviv</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="401" to="409" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Peoples AR, Garland SN, Perlis ML, et al. Effects of cognitive behavioral therapy for insomnia and armodafinil on quality of life in cancer survivors: a randomized placebo-controlled trial. J Cancer Surviv. 2017;11(3):401-409. doi:10.1007/s11764-017-0597- 0</note>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main" xml:id="_ZyCS555">Cognitive-behavior therapy singly and combined with medication for persistent insomnia: impact on psychological and daytime functioning</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Morin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beaulieu-Bonneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bélanger</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brat.2016.09.002</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Cn47ve9">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">87</biblScope>
			<biblScope unit="page" from="109" to="116" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Morin CM, Beaulieu-Bonneau S, Bélanger L, et al. Cognitive-behavior therapy singly and combined with medication for persistent insomnia: impact on psychological and daytime functioning. Behav Res Ther. 2016;87:109-116. doi:10.1016/j.brat .2016.09.002</note>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main" xml:id="_FbbuDBp">Treating primary insomnia: clinical effectiveness and predictors of outcomes on sleep, daytime function and health-related quality of life</title>
		<author>
			<persName><forename type="first">L</forename><surname>Van Houdenhove</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Buyse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gabriëls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Van Den Bergh</surname></persName>
		</author>
		<idno type="DOI">10.1007/s10880-011-9250-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_4C6rNTS">J Clin Psychol Med Settings</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="312" to="321" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Van Houdenhove L, Buyse B, Gabriëls L, Van den Bergh O. Treating primary insomnia: clinical effectiveness and predictors of outcomes on sleep, daytime function and health-related quality of life. J Clin Psychol Med Settings. 2011;18(3):312-321. doi: 10.1007/s10880-011-9250-7</note>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main" xml:id="_8XvC44X">Effect of Digital Cognitive Behavioral Therapy for Insomnia on Measures of Health and Well-being Original Investigation Research jamapsychiatry</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Palermo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Beals-Erickson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bromberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Law</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<idno type="DOI">10.5664/jcsm.6490</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_u7FX4sR">J Clin Sleep Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="401" to="410" />
			<date type="published" when="2017-01">2017. January 2019</date>
		</imprint>
	</monogr>
	<note>A single arm pilot trial of brief cognitive behavioral therapy for insomnia in adolescents with physical and psychiatric comorbidities Reprinted JAMA Psychiatry</note>
	<note type="raw_reference">Palermo TM, Beals-Erickson S, Bromberg M, Law E, Chen M. A single arm pilot trial of brief cognitive behavioral therapy for insomnia in adolescents with physical and psychiatric comorbidities. J Clin Sleep Med. 2017;13(3):401-410. doi:10.5664/jcsm.6490 Effect of Digital Cognitive Behavioral Therapy for Insomnia on Measures of Health and Well-being Original Investigation Research jamapsychiatry.com (Reprinted) JAMA Psychiatry January 2019 Volume 76, Number 1</note>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main" xml:id="_rgjddJw">Cognitive behavioral therapy for insomnia in the context of cardiovascular conditions</title>
		<author>
			<persName><forename type="first">S</forename><surname>Conley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">S</forename><surname>Redeker</surname></persName>
		</author>
		<idno type="DOI">10.1007/s40675-015-0019-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_9XtedVX">Curr Sleep Med Rep</title>
		<imprint>
			<biblScope unit="volume">1</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="157" to="165" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Conley S, Redeker NS. Cognitive behavioral therapy for insomnia in the context of cardiovascular conditions. Curr Sleep Med Rep. 2015;1(3):157-165. doi:10.1007/s40675-015-0019-7</note>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main" xml:id="_ZQ7jYZP">Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Mathers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tomeny</surname></persName>
		</author>
		<idno type="DOI">10.1207/s15402010bsm0402_1</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_AuWpcS3">Behav Sleep Med</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page" from="71" to="84" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dixon S, Morgan K, Mathers N, Thompson J, Tomeny M. Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia. Behav Sleep Med. 2006;4(2):71-84. doi:10.1207/s15402010bsm0402 _1</note>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main" xml:id="_SVYBRKN">Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cassidy</surname></persName>
		</author>
		<idno type="DOI">10.1200/jco.2007.13.9006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dwD74rQ">J Clin Oncol</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="issue">28</biblScope>
			<biblScope unit="page" from="4651" to="4658" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Fleming L, Cassidy J, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26(28): 4651-4658. doi:10.1200/JCO.2007.13.9006</note>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main" xml:id="_34d96RQ">Attribution, cognition and psychopathology in persistent insomnia disorder: outcome and mediation analysis from a randomized placebo-controlled trial of online cognitive behavioural therapy</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hames</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fleming</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.sleep.2014.03.001</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GpWhzrm">Sleep Med</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="913" to="917" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Kyle SD, Miller CB, Ong J, Hames P, Fleming L. Attribution, cognition and psychopathology in persistent insomnia disorder: outcome and mediation analysis from a randomized placebo-controlled trial of online cognitive behavioural therapy. Sleep Med. 2014;15(8):913-917. doi:10.1016/j.sleep.2014.03.001</note>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main" xml:id="_R7tHyq2">The anxiolytic effects of cognitive behavior therapy for insomnia: preliminary results from a web-delivered protocol</title>
		<author>
			<persName><forename type="first">V</forename><surname>Pillai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Cheng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j" xml:id="_btZAQjn">J Sleep Med Disord</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="issue">2</biblScope>
			<biblScope unit="page">1017</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Pillai V, Anderson JR, Cheng P, et al. The anxiolytic effects of cognitive behavior therapy for insomnia: preliminary results from a web-delivered protocol. J Sleep Med Disord. 2015;2(2):1017.</note>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main" xml:id="_9dQSRZB">Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia</title>
		<author>
			<persName><forename type="first">R</forename><surname>Manber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Edinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Gress</surname></persName>
		</author>
		<author>
			<persName><forename type="first">San</forename><surname>Pedro-Salcedo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Kuo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">F</forename><surname>Kalista</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
		<idno type="DOI">10.1093/sleep/31.4.489</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_e9MRrT7">Sleep</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="489" to="495" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep. 2008;31(4):489-495. doi:10.1093/sleep/31.4.489</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main" xml:id="_6sJQ6Vm">The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sheaves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Goodwin</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2215-0366(17)30328-0</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_2YzpFxp">Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="749" to="758" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Freeman D, Sheaves B, Goodwin GM, et al. The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis. Lancet Psychiatry. 2017;4(10): 749-758. doi:10.1016/S2215-0366(17)30328-0</note>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main" xml:id="_2davpMr">Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial</title>
		<author>
			<persName><forename type="first">H</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Batterham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gosling</surname></persName>
		</author>
		<idno type="DOI">10.1016/s2215-0366(15)00536-2</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3R7byCX">Lancet Psychiatry</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">4</biblScope>
			<biblScope unit="page" from="333" to="341" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Christensen H, Batterham PJ, Gosling JA, et al. Effectiveness of an online insomnia program (SHUTi) for prevention of depressive episodes (the GoodNight Study): a randomised controlled trial. Lancet Psychiatry. 2016;3(4):333-341. doi:10.1016 /S2215-0366(15)00536-2</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main" xml:id="_uXbMZmr">Cognitive behavioral therapy for insomnia in older veterans using nonclinician sleep coaches: randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><surname>Alessi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fiorentino</surname></persName>
		</author>
		<idno type="DOI">10.1111/jgs.14304</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_hnZbtsZ">J Am Geriatr Soc</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="1830" to="1838" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Alessi C, Martin JL, Fiorentino L, et al. Cognitive behavioral therapy for insomnia in older veterans using nonclinician sleep coaches: randomized controlled trial. J Am Geriatr Soc. 2016;64(9):1830- 1838. doi:10.1111/jgs.14304</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main" xml:id="_msvwNfv">Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone</title>
		<author>
			<persName><forename type="first">S</forename><surname>Omvik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Sivertsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Pallesen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bjorvatn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">E</forename><surname>Havik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Nordhus</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.brat.2008.02.013</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_G8xr55P">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="623" to="641" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Omvik S, Sivertsen B, Pallesen S, Bjorvatn B, Havik OE, Nordhus IH. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone. Behav Res Ther. 2008;46(5): 623-641. doi:10.1016/j.brat.2008.02.013</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main" xml:id="_jRkrFuh">Is restricted randomisation necessary?</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Hewitt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Torgerson</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.332.7556.1506</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_GspgYSX">BMJ</title>
		<imprint>
			<biblScope unit="volume">332</biblScope>
			<biblScope unit="issue">7556</biblScope>
			<biblScope unit="page" from="1506" to="1508" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hewitt CE, Torgerson DJ. Is restricted randomisation necessary? BMJ. 2006;332(7556): 1506-1508. doi:10.1136/bmj.332.7556.1506</note>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main" xml:id="_8GbvFrz">Digital cognitive behavioural therapy for insomnia versus sleep hygiene education: the impact of improved sleep on functional health, quality of life and psychological well-being: study protocol for a randomised controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Luik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cape</surname></persName>
		</author>
		<idno type="DOI">10.1186/s13063-016-1364-7</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UKwXywu">Trials</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page">257</biblScope>
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Luik AI, Cape J, et al. Digital cognitive behavioural therapy for insomnia versus sleep hygiene education: the impact of improved sleep on functional health, quality of life and psychological well-being: study protocol for a randomised controlled trial. Trials. 2016;17(1):257. doi:10.1186/s13063-016-1364-7</note>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main" xml:id="_XGmwK4g">The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Hames</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gardani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Fleming</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cape</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmjopen-2013-004183</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_Tjte2dg">BMJ Open</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page">4183</biblScope>
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Kyle SD, Hames P, Gardani M, Fleming L, Cape J. The Sleep Condition Indicator: a clinical screening tool to evaluate insomnia disorder. BMJ Open. 2014;4(3):e004183. doi:10 .1136/bmjopen-2013-004183 40</note>
</biblStruct>

<biblStruct xml:id="b39">
	<monogr>
		<idno type="DOI">10.1089/glre.2016.201011</idno>
		<ptr target="http://www.greatbritishsleepsurvey.com" />
		<title level="m" xml:id="_WyHSQtd">The Great British Sleep Survey</title>
		<imprint>
			<date type="published" when="2018-09-12">September 12, 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The Great British Sleep Survey. http://www.greatbritishsleepsurvey.com. Accessed September 12, 2018.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<idno type="DOI">10.1089/glre.2016.201011</idno>
		<ptr target="http://www.worldsleepsurvey.com" />
		<title level="m" xml:id="_CkzQuDc">The World Sleep Survey</title>
		<imprint>
			<date type="published" when="2018-09-12">September 12, 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">The World Sleep Survey. http://www .worldsleepsurvey.com. Accessed September 12, 2018.</note>
</biblStruct>

<biblStruct xml:id="b41">
	<monogr>
		<title/>
		<author>
			<persName><surname>Sleepio</surname></persName>
		</author>
		<ptr target="https://www.sleepio.com" />
		<imprint>
			<date type="published" when="2018-09-12">September 12, 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Sleepio. https://www.sleepio.com. Accessed September 12, 2018.</note>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main" xml:id="_tdpwhaZ">A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.5665/sleep.1872</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_DDmks63">Sleep</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="769" to="781" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Kyle SD, Williams C, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35(6):769-781. doi:10 .5665/sleep.1872</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main" xml:id="_FaA5ssX">The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Inglis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tessier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Harvey</surname></persName>
		</author>
		<idno type="DOI">10.1016/s0005-7967(99)00157-6</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_448E66r">Behav Res Ther</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="45" to="60" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, Inglis SJ, Tessier S, Harvey L. The clinical effectiveness of cognitive behaviour therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 2001;39(1):45-60. doi:10 .1016/S0005-7967(99)00157-6</note>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main" xml:id="_kJrTudm">Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Macmahon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Kelly</surname></persName>
		</author>
		<idno type="DOI">10.1093/sleep/30.5.574</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_sxXHTWa">Sleep</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="574" to="584" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA, MacMahon KM, Kelly HL, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007;30(5):574-584. doi:10.1093/sleep/30.5 .574</note>
</biblStruct>

<biblStruct xml:id="b45">
	<monogr>
		<title level="m" type="main" xml:id="_7HPVNGX">Overcoming Insomnia and Sleep Problems: A Self-help Guide Using Cognitive Behavioral Techniques</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2006">2006</date>
			<publisher>Constable &amp; Robinson Ltd</publisher>
			<pubPlace>London, UK</pubPlace>
		</imprint>
	</monogr>
	<note type="raw_reference">Espie CA. Overcoming Insomnia and Sleep Problems: A Self-help Guide Using Cognitive Behavioral Techniques. London, UK: Constable &amp; Robinson Ltd; 2006.</note>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main" xml:id="_4dFsNKv">Sleep to lower elevated blood pressure: a randomized controlled trial (SLEPT)</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">R</forename><surname>Mcgrath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Power</surname></persName>
		</author>
		<idno type="DOI">10.1093/ajh/hpw132</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_jU262VF">Am J Hypertens</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="319" to="327" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">McGrath ER, Espie CA, Power A, et al. Sleep to lower elevated blood pressure: a randomized controlled trial (SLEPT). Am J Hypertens. 2017;30 (3):319-327. doi:10.1093/ajh/hpw132</note>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main" xml:id="_Cq7DZ7Q">Sleep and productivity benefits of digital cognitive behavioral therapy for insomnia: a randomized controlled trial conducted in the workplace environment</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bostock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Luik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<idno type="DOI">10.1097/jom.0000000000000778</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ScmQsAN">J Occup Environ Med</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="683" to="689" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Bostock S, Luik AI, Espie CA. Sleep and productivity benefits of digital cognitive behavioral therapy for insomnia: a randomized controlled trial conducted in the workplace environment. J Occup Environ Med. 2016;58(7):683-689. doi:10.1097 /JOM.0000000000000778</note>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main" xml:id="_9k8zQHz">Helping employees sleep well: effects of cognitive behavioral therapy for insomnia on work outcomes</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Barnes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bostock</surname></persName>
		</author>
		<idno type="DOI">10.1037/apl0000154</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_pZuSCqm">J Appl Psychol</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="issue">1</biblScope>
			<biblScope unit="page" from="104" to="113" />
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Barnes CM, Miller JA, Bostock S. Helping employees sleep well: effects of cognitive behavioral therapy for insomnia on work outcomes. J Appl Psychol. 2017; 102(1):104-113. doi:10.1037 /apl0000154</note>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main" xml:id="_DWDcJAd">The efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized controlled trial</title>
		<author>
			<persName><forename type="first">P</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Luik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Fellman-Couture</surname></persName>
		</author>
		<idno type="DOI">10.1017/S0033291718001113</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_yBYptgD">Psychol Med</title>
		<imprint>
			<date type="published" when="2018-05-24">May 24, 2018</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheng P, Luik AI, Fellman-Couture C, et al. The efficacy of digital CBT for insomnia to reduce depression across demographic groups: a randomized controlled trial [published online May 24, 2018]. Psychol Med. doi:10.1017 /S0033291718001113 51</note>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main" xml:id="_QJqQHrk">How to Sleep Better</title>
		<idno type="DOI">10.1093/oso/9780195306590.005.0002</idno>
		<imprint>
			<date type="published" when="2012">2012</date>
			<publisher>American Academy of Sleep Medicine</publisher>
			<pubPlace>Darien, IL</pubPlace>
		</imprint>
		<respStmt>
			<orgName>American Academy of Sleep Medicine</orgName>
		</respStmt>
	</monogr>
	<note type="raw_reference">American Academy of Sleep Medicine. How to Sleep Better. Darien, IL: American Academy of Sleep Medicine; 2012.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main" xml:id="_GCBXmwg">Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Hays</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Bjorner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Revicki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Spritzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Cella</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11136-009-9496-9</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_7t83WkX">Qual Life Res</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="873" to="880" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hays RD, Bjorner JB, Revicki DA, Spritzer KL, Cella D. Development of physical and mental health summary scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items. Qual Life Res. 2009;18(7): 873-880. doi:10.1007/s11136-009-9496-9</note>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main" xml:id="_XTERKyc">The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation</title>
		<author>
			<persName><forename type="first">R</forename><surname>Tennant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hiller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fishwick</surname></persName>
		</author>
		<idno type="DOI">10.1186/1477-7525-5-63</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_VjyM9CA">Health Qual Life Outcomes</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page">63</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tennant R, Hiller L, Fishwick R, et al. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS): development and UK validation. Health Qual Life Outcomes. 2007;5:63. doi:10.1186 /1477-7525-5-63</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main" xml:id="_grm7yb6">The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Crawford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Spiegelhalder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Clark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.sleep.2012.10.023</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_fRGSJSk">Sleep Med</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="493" to="501" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kyle SD, Crawford MR, Morgan K, Spiegelhalder K, Clark AA, Espie CA. The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in insomnia disorder. Sleep Med. 2013;14(6):493-501. doi:10.1016/j.sleep.2012.10.023</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main" xml:id="_vzf27Za">The PHQ-9: validity of a brief depression severity measure</title>
		<author>
			<persName><forename type="first">K</forename><surname>Kroenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Spitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Williams</surname></persName>
		</author>
		<idno type="DOI">10.1046/j.1525-1497.2001.016009606.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_MHfZ3Kw">J Gen Intern Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="issue">9</biblScope>
			<biblScope unit="page" from="606" to="613" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-613. doi:10.1046 /j.1525-1497.2001.016009606.x</note>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main" xml:id="_7rE4z3e">A brief measure for assessing generalized anxiety disorder: the GAD-7</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Spitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kroenke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Löwe</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/archinte.166.10.1092&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamapsychiatry.2018.2745</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dH5fcmw">Arch Intern Med</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="1092" to="1097" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166 (10):1092-1097. doi:10.1001/archinte.166.10.1092</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main" xml:id="_cvnuQSu">The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia</title>
		<author>
			<persName><forename type="first">M</forename><surname>Gradisar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Richards</surname></persName>
		</author>
		<idno type="DOI">10.5664/jcsm.27030</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_ADycUYE">J Clin Sleep Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="issue">7</biblScope>
			<biblScope unit="page" from="722" to="728" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gradisar M, Lack L, Richards H, et al. The Flinders Fatigue Scale: preliminary psychometric properties and clinical sensitivity of a new scale for measuring daytime fatigue associated with insomnia. J Clin Sleep Med. 2007;3(7):722-728.</note>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main" xml:id="_Dq9vBEM">The Relationship Assessment Scale</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Hendrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dicke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hendrick</surname></persName>
		</author>
		<idno type="DOI">10.1177/0265407598151009</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_5R9bu4F">J Soc Pers Relat</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="137" to="142" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Hendrick SS, Dicke A, Hendrick C. The Relationship Assessment Scale. J Soc Pers Relat. 1998;15:137-142. doi:10.1177/0265407598151009</note>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main" xml:id="_BPTYewN">The Cognitive Failures Questionnaire (CFQ) and its correlates</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Broadbent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">F</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Parkes</surname></persName>
		</author>
		<idno type="DOI">10.1111/j.2044-8260.1982.tb01421.x</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tekP7CQ">Br J Clin Psychol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="issue">pt 1</biblScope>
			<biblScope unit="page" from="1" to="16" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(pt 1):1-16. doi:10.1111/j.2044-8260.1982.tb01421.x</note>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main" xml:id="_Dk7RKpd">The validity and reproducibility of a work productivity and activity impairment instrument</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Zbrozek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">M</forename><surname>Dukes</surname></persName>
		</author>
		<idno type="DOI">10.2165/00019053-199304050-00006</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_3q82WNU">Pharmacoeconomics</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="issue">5</biblScope>
			<biblScope unit="page" from="353" to="365" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics. 1993;4(5):353-365. doi:10.2165/00019053- 199304050-00006</note>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main" xml:id="_su9jjbJ">Reliability and validity of a single-item measure of job satisfaction</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Dolbier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Webster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">T</forename><surname>Mccalister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Mallon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Steinhardt</surname></persName>
		</author>
		<idno type="DOI">10.4278/0890-1171-19.3.194</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_uCRq3F8">Am J Health Promot</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="194" to="198" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dolbier CL, Webster JA, McCalister KT, Mallon MW, Steinhardt MA. Reliability and validity of a single-item measure of job satisfaction. Am J Health Promot. 2005;19(3):194-198. doi:10.4278/0890- 1171-19.3.194</note>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main" xml:id="_t6q7B5M">A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Johns</surname></persName>
		</author>
		<idno type="DOI">10.1093/sleep/14.6.540</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_kJmDsA3">Sleep</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="540" to="545" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540-545. doi:10.1093/sleep/14.6 .540</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main" xml:id="_P9WePAt">Assessing the validity of single-item life satisfaction measures: results from three large samples</title>
		<author>
			<persName><forename type="first">F</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Lucas</surname></persName>
		</author>
		<idno type="DOI">10.1007/s11136-014-0726-4</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_xtMq4eX">Qual Life Res</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="issue">10</biblScope>
			<biblScope unit="page" from="2809" to="2818" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Cheung F, Lucas RE. Assessing the validity of single-item life satisfaction measures: results from three large samples. Qual Life Res. 2014;23(10): 2809-2818. doi:10.1007/s11136-014-0726-4</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main" xml:id="_f7E7vDv">No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Kyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Spiegelhalder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Espie</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.sleep.2011.03.016</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_A63PTTS">Sleep Med</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="issue">8</biblScope>
			<biblScope unit="page" from="735" to="747" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med. 2011;12(8):735-747. doi:10 .1016/j.sleep.2011.03.016</note>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main" xml:id="_Zwfnvpd">Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gueorguieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Krystal</surname></persName>
		</author>
		<idno type="DOI">https://jama.jamanetwork.com/article.aspx?doi=10.1001/archpsyc.61.3.310&amp;utm_campaign=articlePDF%26utm_medium=articlePDFlink%26utm_source=articlePDF%26utm_content=jamapsychiatry.2018.2745</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_tqtRp8h">Arch Gen Psychiatry</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="issue">3</biblScope>
			<biblScope unit="page" from="310" to="317" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Gueorguieva R, Krystal JH. Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry. 2004;61 (3):310-317. doi:10.1001/archpsyc.61.3.310</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main" xml:id="_m5A2u7e">The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Baron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Kenny</surname></persName>
		</author>
		<idno type="DOI">10.1037/0022-3514.51.6.1173</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_46k2mNd">J Pers Soc Psychol</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="issue">6</biblScope>
			<biblScope unit="page" from="1173" to="1182" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173-1182. doi:10.1037 /0022-3514.51.6.1173</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main" xml:id="_UqN24QE">Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme</title>
		<author>
			<persName><forename type="first">G</forename><surname>Dunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Emsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Liu</surname></persName>
		</author>
		<idno type="DOI">10.3310/hta19930</idno>
		<idno>doi:10.3310/</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_UvKebrb">Health Technol Assess</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="issue">93</biblScope>
			<biblScope unit="page" from="1" to="115" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Dunn G, Emsley R, Liu H, et al. Evaluation and validation of social and psychological markers in randomised trials of complex interventions in mental health: a methodological research programme. Health Technol Assess. 2015;19(93):1-115, v-vi. v-vi. doi:10.3310/</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
